: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Influenza

Free Subscription

Articles published in J Infect
Retrieve available abstracts of 888 articles:
HTML format

Single Articles

March 2024

SUN L, Man Q, Zhang H, Xia S, et al
Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination.
J Infect. 2024;88:106138.
PubMed

MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, de Mendoza C, et al
COVID-19 Mortality Amongst the Immunosuppresed.
J Infect. 2024 Mar 11:106137. doi: 10.1016/j.jinf.2024.106137.
PubMed

FATLY ZA, Betjes MGH, Dik WA, Fouchier RAM, et al
Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: results from a randomized controlled study.
J Infect. 2024 Mar 1:106133. doi: 10.1016/j.jinf.2024.106133.
PubMed Abstract available

February 2024

LIU P, Cai J, Tian H, Li J, et al
Intra-host genetic diversity of SARS-CoV-2 Omicron variants in children.
J Infect. 2024 Feb 29:106132. doi: 10.1016/j.jinf.2024.106132.
PubMed

MEERAUS W, Joy M, Ouwens M, Taylor KS, et al
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study.
J Infect. 2024 Feb 29:106129. doi: 10.1016/j.jinf.2024.106129.
PubMed Abstract available

HAYWARD G, Yu LM, Little P, Gbinigie O, et al
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
J Infect. 2024 Feb 29:106130. doi: 10.1016/j.jinf.2024.106130.
PubMed Abstract available

ZHOU J, Lan L, Ai S, Lin J, et al
People Living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention.
J Infect. 2024 Feb 15:106122. doi: 10.1016/j.jinf.2024.106122.
PubMed

HITES M, Massonnaud CR, Jamard S, Goehringer F, et al
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): a phase 3, randomized, double-blind, placebo-controlled trial.
J Infect. 2024 Feb 15:106120. doi: 10.1016/j.jinf.2024.106120.
PubMed

YAO Z, Zhang L, Duan Y, Tang X, et al
Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.
J Infect. 2024 Feb 15:106121. doi: 10.1016/j.jinf.2024.106121.
PubMed Abstract available

KALKERI R, Zhu M, Cloney-Clark S, Plested JS, et al
Altered IgG4 Antibody Response to Repeated mRNA versus Recombinant Protein SARS-CoV-2 Vaccines.
J Infect. 2024 Feb 13:106119. doi: 10.1016/j.jinf.2024.106119.
PubMed

XIE L, Luo G, Yang Z, Wu WC, et al
The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract.
J Infect. 2024 Feb 9:S0163-4453(24)00036-7. doi: 10.1016/j.jinf.2024.
PubMed Abstract available

HUNG KC, Chen IW, Sun CK
Pulmonary dysfunction severity may impact optimal dexamethasone dosing in patients with COVID-19.
J Infect. 2024 Feb 1:S0163-4453(24)00031-8. doi: 10.1016/j.jinf.2024.
PubMed

January 2024

LESTON M, Elson W, Ordonez-Mena JM, Kar D, et al
Disparities in COVID-19 Mortality Amongst the Immunosuppressed: A Systematic Review and Meta-analysis for Enhanced Disease Surveillance.
J Infect. 2024 Jan 30:S0163-4453(24)00028-8. doi: 10.1016/j.jinf.2024.
PubMed Abstract available

KE YK, Han XY, Lin SR, Wu HG, et al
Emergence of a triple reassortment avian influenza virus (A/H5N6) from wild birds.
J Infect. 2024 Jan 17:S0163-4453(24)00024-0. doi: 10.1016/j.jinf.2024.
PubMed

MURRAY JM, Murray DD, Schvoerer E, Akand EH, et al
SARS-CoV-2 Delta and Omicron community transmission networks as added value to contact tracing.
J Infect. 2024 Jan 17:S0163-4453(24)00023-9. doi: 10.1016/j.jinf.2024.
PubMed Abstract available

CORNISH EF, van der Meeren LE, van der Hoorn MP, Schoenmakers S, et al
Stillbirths due to placental COVID infection associated with chronic histiocytic intervillositis do not recur in subsequent pregnancies.
J Infect. 2024 Jan 11:S0163-4453(24)00020-3. doi: 10.1016/j.jinf.2024.
PubMed

ZHANG H, Zhou K, Peng F, Gao Z, et al
Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency.
J Infect. 2024 Jan 6:S0163-4453(23)00600-X. doi: 10.1016/j.jinf.2023.
PubMed

December 2023

ZONG K, Yuan P, Wang R, Luo Q, et al
Characteristics of innate, humoral and cellular immunity in children with non-severe SARS-CoV-2 infection.
J Infect. 2023 Dec 13:S0163-4453(23)00589-3. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

FERNANDEZ-DE-LAS-PENAS C, Notarte KI, Macasaet R, Velasco JV, et al
Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis.
J Infect. 2023 Dec 13:S0163-4453(23)00590-X. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

STRAHM C, Kahlert CR, Gusewell S, Vuichard-Gysin D, et al
Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection: A prospective healthcare worker cohort.
J Infect. 2023 Dec 7:S0163-4453(23)00588-1. doi: 10.1016/j.jinf.2023.
PubMed

PAN D, Hui DSC, Tang JW
Defining infection transmission pathways for future pandemic preparedness - An urgent public health research priority.
J Infect. 2023;87:595-597.
PubMed

AO G, Li T, Nasr B, Wang Y, et al
The effect of dupilumab on clinical outcomes in patients with COVID-19: A meta-analysis.
J Infect. 2023;87:e107-e109.
PubMed

LIU Y, Sun R, Zhang H, Huang J, et al
Trends and predictions of tuberculosis notification in mainland China during and after the COVID-19 pandemic.
J Infect. 2023;87:e100-e103.
PubMed

November 2023

PHAN J, Eslick GD, Elliott EJ
Demystifying the global outbreak of severe acute hepatitis of unknown aetiology in children: A systematic review and meta-analysis.
J Infect. 2023 Nov 24:S0163-4453(23)00580-7. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

GRAU S, Vela JM, Gurt A, Barcelo-Vidal J, et al
Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients.
J Infect. 2023 Nov 20:S0163-4453(23)00562-5. doi: 10.1016/j.jinf.2023.
PubMed

DIEP AN, Schyns J, Gourzones C, Goffin E, et al
How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity dynamics: an 18-month longitudinal study.
J Infect. 2023 Nov 17:S0163-4453(23)00558-3. doi: 10.1016/j.jinf.2023.
PubMed

BRENDISH NJ, Davis C, Chapman ME, Borca F, et al
Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation.
J Infect. 2023 Nov 15:S0163-4453(23)00556-X. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

LIECHTI FD, Bijlsma MW, Brouwer MC, van Sorge NM, et al
Impact of the COVID-19 pandemic on incidence and serotype distribution of pneumococcal meningitis - A prospective, nationwide cohort study from the Netherlands.
J Infect. 2023 Nov 8:S0163-4453(23)00555-8. doi: 10.1016/j.jinf.2023.
PubMed

HALL VJ, Insalata F, Foulkes S, Kirwan P, et al
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022.
J Infect. 2023 Nov 3:S0163-4453(23)00553-4. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

LUNT R, Quinot C, Kirsebom F, Andrews N, et al
The Impact of Vaccination and SARS-CoV-2 Variants on the Virological Response to SARS-CoV-2 Infections during the Alpha, Delta, and Omicron waves in England.
J Infect. 2023 Nov 3:S0163-4453(23)00547-9. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

October 2023

BRUHN M, Obara M, Chiyyeadu A, Costa B, et al
Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutation.
J Infect. 2023 Oct 30:S0163-4453(23)00551-0. doi: 10.1016/j.jinf.2023.
PubMed

JIANG W, Xu L, Wang Y, Hao C, et al
Exploring immunity debt: Dynamic alterations in RSV antibody levels in children under 5 years during the COVID-19 pandemic.
J Infect. 2023 Oct 29:S0163-4453(23)00550-9. doi: 10.1016/j.jinf.2023.
PubMed

JIN Z, Wu J, Wang Y, Huang T, et al
Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.
J Infect. 2023 Oct 26:S0163-4453(23)00543-1. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

HA L, Levian C, Greene N, Goldfarb I, et al
Association between acceptance of routine pregnancy vaccinations and COVID-19 vaccine uptake in pregnant patients.
J Infect. 2023 Oct 19:S0163-4453(23)00541-8. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

MARJANEH MM, Challenger JD, Salas A, Gomez-Carballa A, et al
Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract.
J Infect. 2023 Oct 18:S0163-4453(23)00540-6. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

FENWICK C, Turelli P, Duhoo Y, Lau K, et al
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys.
J Infect. 2023 Oct 16:S0163-4453(23)00539-X. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

LU XM, Feng XY, Wu Y, Wen CB, et al
Genetic characterization of a novel H5N6 subtype highly pathogenic avian influenza virus from goose in China.
J Infect. 2023 Oct 12:S0163-4453(23)00533-9. doi: 10.1016/j.jinf.2023.
PubMed

BEARD KR, Borca F, Phan H, Brown E, et al
Routine, molecular point-of-care testing for SARS-CoV-2 and other respiratory viruses within an acute oncology service improves patient care.
J Infect. 2023 Oct 4:S0163-4453(23)00514-5. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

TIAN S, Liu T, Zhao XJ, Liu XL, et al
Neutralization against emerging Omicron subvariants after SARS-CoV-2 reinfection.
J Infect. 2023 Oct 4:S0163-4453(23)00515-7. doi: 10.1016/j.jinf.2023.
PubMed

September 2023

VELLAS C, Latour J, Tremeaux P, Ranger N, et al
Molecular Evolution of Omicron Variant in Immunocompromised Individuals with Chronic SARS-CoV-2 Infection.
J Infect. 2023 Sep 30:S0163-4453(23)00513-3. doi: 10.1016/j.jinf.2023.
PubMed

ANTONELLI M, Penfold RS, Canas LDS, Sudre C, et al
SARS-CoV-2 infection following booster vaccination: illness and symptom profile in a prospective, observational community-based case-control study.
J Infect. 2023 Sep 28:S0163-4453(23)00461-9. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

GAO Y, Zhang Y, Mou K, Man S, et al
Alterations in the outer retina and choroid in patients after COVID-19 infection.
J Infect. 2023 Sep 27:S0163-4453(23)00512-1. doi: 10.1016/j.jinf.2023.
PubMed

YAMAMOTO S, Mizoue T, Konishi M, Oshiro Y, et al
Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2 reinfection.
J Infect. 2023 Sep 26:S0163-4453(23)00511-X. doi: 10.1016/j.jinf.2023.
PubMed

SNOW TAC, Arulkumaran N, Singer M, Choi SH, et al
Effect of dexamethasone dose on outcomes in acute COVID-19 disease: a systematic review and meta-analysis.
J Infect. 2023 Sep 25:S0163-4453(23)00510-8. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

MATSUO OM, Lindoso L, Sousa Marques HH, Polanczyk GV, et al
Mental health among children and adolescents after SARS-CoV-2 infection: a prospective study in a tertiary university hospital.
J Infect. 2023 Sep 20:S0163-4453(23)00507-8. doi: 10.1016/j.jinf.2023.
PubMed

CHEN JM, Tan SM, Chen RX, Gong HY, et al
Distribution and risks of the infections of humans and other mammals with H5 subtype highly pathogenic avian influenza viruses in 2020-2023.
J Infect. 2023 Sep 7:S0163-4453(23)00505-4. doi: 10.1016/j.jinf.2023.
PubMed

DOWELL AC, Tut G, Begum J, Bruton R, et al
Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
J Infect. 2023 Sep 1:S0163-4453(23)00465-6. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

August 2023

GUAN X, Huang Q, Dong M, Li M, et al
SARS-CoV-2-specific antibody and T-cell immunity in convalescents after infection wave in Beijing in late 2022.
J Infect. 2023 Aug 29:S0163-4453(23)00462-0. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

WHITAKER HJ, Tsang RS, Byford R, Aspden C, et al
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
J Infect. 2023 Aug 12:S0163-4453(23)00456-5. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

WAGENHAUSER I, Mees J, Reusch J, Lam TT, et al
Determinants of Influenza A Infection Rate in Post-COVID-19 Era.
J Infect. 2023 Aug 9:S0163-4453(23)00455-3. doi: 10.1016/j.jinf.2023.
PubMed

FAUSTINI SE, Cook A, Hill H, Al-Taei S, et al
Saliva antiviral antibody levels are detectable but correlate poorly with serum antibody levels following SARS-CoV-2 infection and/or vaccination.
J Infect. 2023 Aug 3:S0163-4453(23)00439-5. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

July 2023

YAO XY, Lian CY, Lv ZH, Zhang XL, et al
Emergence of a novel reassortant H5N6 subtype highly pathogenic avian influenza virus in farmed dogs in China.
J Infect. 2023 Jul 26:S0163-4453(23)00386-9. doi: 10.1016/j.jinf.2023.
PubMed

SUN B, Gao F
Investigation of escape mechanisms of SARS-CoV-2 Omicron sub-lineages and exploration of potential antibodies for XBB.1.
J Infect. 2023 Jul 26:S0163-4453(23)00387-0. doi: 10.1016/j.jinf.2023.
PubMed

PIERANGELI A, Nenna R, Fracella M, Scagnolari C, et al
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome.
J Infect. 2023 Jul 24:S0163-4453(23)00381-X. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

THEODOSIOU AA, Read RC
Artificial Intelligence, Machine Learning and Deep Learning: Potential Resources for the Infection Clinician.
J Infect. 2023 Jul 17:S0163-4453(23)00379-1. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

KAMBOJ M, Laracy JC, Usiak S, Babady NE, et al
Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants.
J Infect. 2023 Jul 13:S0163-4453(23)00378-X. doi: 10.1016/j.jinf.2023.
PubMed

FEELISCH M, Clark AD, Cumpstey AF, Santolini J, et al
Long COVID: Potential role of the Reactive Species Interactome.
J Infect. 2023 Jul 11:S0163-4453(23)00376-6. doi: 10.1016/j.jinf.2023.
PubMed

RISSMANN M, Veldhuis Kroeze EJB, Tielens AGM, Rockx B, et al
Influence of a chronic Schistosoma mansoni infection on the outcomes of a SARS-CoV-2 infection in the hamster model.
J Infect. 2023 Jul 5:S0163-4453(23)00374-2. doi: 10.1016/j.jinf.2023.
PubMed

BAYHAN GI, Guner R, Yahsi A, Ozkul A, et al
Evaluation of the neutralizing antibody response against the omicron variant produced by heterologous or hybrid immunity: How does the fifth dose of COVID-19 vaccine affect the neutralizing antibody response?
J Infect. 2023 Jul 4:S0163-4453(23)00369-9. doi: 10.1016/j.jinf.2023.
PubMed

TAUCHER C, Lazarus R, Dellago H, Maurer G, et al
Safety and Immunogenicity against Ancestral, Delta and Omicron Virus Variants Following a Booster Dose of an Inactivated Whole-Virus COVID-19 Vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COM
J Infect. 2023 Jul 3:S0163-4453(23)00367-5. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

June 2023

VARASI I, Lai A, Fiaschi L, Bergna A, et al
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination.
J Infect. 2023 Jun 30:S0163-4453(23)00342-0. doi: 10.1016/j.jinf.2023.
PubMed

WU JY, Hsu WH, Tsai YW, Liu TH, et al
The association between zinc deficiency, and clinical outcomes of COVID-19.
J Infect. 2023 Jun 29:S0163-4453(23)00343-2. doi: 10.1016/j.jinf.2023.
PubMed

DOWELL AC, Waiblinger D, Wright J, Ladhani SN, et al
Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2 Reinfection in Children.
J Infect. 2023 Jun 28:S0163-4453(23)00340-7. doi: 10.1016/j.jinf.2023.
PubMed

SU HC, Lai ZL, Chang YC, Cheng MY, et al
Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan.
J Infect. 2023 Jun 27:S0163-4453(23)00341-9. doi: 10.1016/j.jinf.2023.
PubMed

HAGIYA H, Osaki Y, Yamamoto M, Niimura T, et al
Global trends of seasonal influenza-associated mortality in 2001-2018: A longitudinal epidemiological study.
J Infect. 2023 Jun 16:S0163-4453(23)00334-1. doi: 10.1016/j.jinf.2023.
PubMed

KELLY E, Greenland M, de Whalley PCS, Aley PK, et al
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A Randomised Controlled Trial.
J Infect. 2023 Jun 16:S0163-4453(23)00330-4. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
AUTHORS' REPLY TO A COMMENTARY ON THE POTENTIAL IMPACT OF COVID-19 PASSPORTS TO EPIDEMIOLOGICAL SITUATION.
J Infect. 2023 Jun 15:S0163-4453(23)00333-X. doi: 10.1016/j.jinf.2023.
PubMed

FALLET B, Foglierini M, Porret R, Alcaraz A, et al
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
J Infect. 2023 Jun 13:S0163-4453(23)00329-8. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

BISHARAT N, Campisi-Pinto S
Determinants of reinfection with SARS-CoV-2 Omicron variant.
J Infect. 2023 Jun 9:S0163-4453(23)00325-0. doi: 10.1016/j.jinf.2023.
PubMed

CAI J, Ruan J, Lin Q, Ren T, et al
China faces the challenge of influenza A virus, including H3N8, in the post-COVID-19 era.
J Infect. 2023 Jun 7:S0163-4453(23)00324-9. doi: 10.1016/j.jinf.2023.
PubMed

MOHN KG, Bredholt G, Onyango TB, Brokstad KA, et al
SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity.
J Infect. 2023 Jun 7:S0163-4453(23)00302-X. doi: 10.1016/j.jinf.2023.
PubMed

PASCALL DJ, Vink E, Blacow R, Bulteel N, et al
Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent.
J Infect. 2023 Jun 1:S0163-4453(23)00297-9. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

May 2023

LIU P, Cheng F, Su L, Ye Z, et al
An outbreak of influenza A in Shanghai after ending the zero-COVID policy in February-March 2023.
J Infect. 2023 May 27:S0163-4453(23)00301-8. doi: 10.1016/j.jinf.2023.
PubMed

NG RW, Sze RK, Chong KC, Zhao S, et al
Effectiveness of mRNA and inactivated COVID-19 vaccines: a test-negative study in an infection-naive Hong Kong population.
J Infect. 2023 May 26:S0163-4453(23)00298-0. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

ZHAO T, Li Y, Xu M, Wang W, et al
High proportion of H3 avian influenza virus circulating in chickens-an increasing threat to public health.
J Infect. 2023 May 24:S0163-4453(23)00296-7. doi: 10.1016/j.jinf.2023.
PubMed

FAVRESSE J, Cabo J, Douxfils J
Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection.
J Infect. 2023 May 19:S0163-4453(23)00292-X. doi: 10.1016/j.jinf.2023.
PubMed

DIAN Y, Meng Y, Sun Y, Deng G, et al
Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities.
J Infect. 2023 May 17:S0163-4453(23)00290-6. doi: 10.1016/j.jinf.2023.
PubMed

NAOURI D, Pham T, Dres M, Vuagnat A, et al
Differences in clinical characteristics and outcomes between COVID-19 and influenza in critically ill adult patients: a national database study.
J Infect. 2023 May 16:S0163-4453(23)00289-X. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

ZHONG X, Pate A, Yang YT, Fahmi A, et al
The impact of COVID -19 on antibiotic prescribing in primary care in England: evaluation and risk prediction of appropriateness of type and repeat prescribing.
J Infect. 2023 May 12:S0163-4453(23)00288-8. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

PINANA M, Gonzalez-Sanchez A, Andres C, Abanto M, et al
The emergence, impact, and evolution of human metapneumovirus variants from 2014 to 2021 in Spain.
J Infect. 2023 May 11:S0163-4453(23)00262-1. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

LV W, He J, Shao J, Chen Y, et al
Causal relationships between short-chain fatty acids and L-isoleucine biosynthesis and susceptibility and severity of COVID-19: Evidence from Mendelian randomization.
J Infect. 2023 May 5:S0163-4453(23)00258-X. doi: 10.1016/j.jinf.2023.
PubMed

GAO M, Ao G, Hao X, Xie B, et al
Casirivimab-Imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis.
J Infect. 2023 May 3:S0163-4453(23)00256-6. doi: 10.1016/j.jinf.2023.
PubMed

April 2023

XU J, Mao D, Liang P, Du P, et al
Undetectable intrauterine transmission during the first trimester of pregnancy in woman after COVID-19 infection.
J Infect. 2023 Apr 26:S0163-4453(23)00255-4. doi: 10.1016/j.jinf.2023.
PubMed

AWAN UA, Hussain M, Qureshi M, Siddique Z, et al
From COVID-19 to Measles: Prioritizing Immunization in Pakistan's Far-Flung Regions.
J Infect. 2023 Apr 26:S0163-4453(23)00253-0. doi: 10.1016/j.jinf.2023.
PubMed

ZHOU Y, Yan H, Zhou Q, Feng R, et al
Impact of COVID-19 control measures on Legionella pneumophila infections in children in Henan, China.
J Infect. 2023 Apr 26:S0163-4453(23)00254-2. doi: 10.1016/j.jinf.2023.
PubMed

AZIZ NA, Nash SG, Zaidi A, Nyberg T, et al
Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England.
J Infect. 2023 Apr 24:S0163-4453(23)00249-9. doi: 10.1016/j.jinf.2023.
PubMed

FURUSE Y
Estimation of excess cardiovascular deaths after COVID-19 in 2020.
J Infect. 2023 Apr 24:S0163-4453(23)00251-7. doi: 10.1016/j.jinf.2023.
PubMed

LIU X, Munro APS, Wright A, Feng S, et al
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
J Infect. 2023 Apr 19:S0163-4453(23)00247-5. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

LUO J, Li A, Liu C, Wang Y, et al
The effect of bebtelovimab on clinical outcomes in patients with COVID-19: a meta-analysis.
J Infect. 2023 Apr 19:S0163-4453(23)00210-4. doi: 10.1016/j.jinf.2023.
PubMed

WEN F, Chen G, Guo J, Guan M, et al
Identification of a duck H9N2 influenza virus possessing tri-basic hemagglutinin cleavage sites genetically close to the human H9N2 isolates in China, 2022.
J Infect. 2023 Apr 17:S0163-4453(23)00207-4. doi: 10.1016/j.jinf.2023.
PubMed

PIGHI L, Henry BM, De Nitto S, Salvagno GL, et al
Cellular immunity against SARS-CoV-2 depends on the serological status.
J Infect. 2023 Apr 13:S0163-4453(23)00203-7. doi: 10.1016/j.jinf.2023.
PubMed

TEYSSOU E, Marot S, Gothland A, Malet I, et al
SARS-CoV-2 variant-dependent inflammasome activation.
J Infect. 2023 Apr 13:S0163-4453(23)00205-0. doi: 10.1016/j.jinf.2023.
PubMed

MORRISON H, Perrin F, Dedicoat M, Ahmed R, et al
Impact of COVID-19 on NHS Tuberculosis Services: Results of a UK-wide survey.
J Infect. 2023 Apr 10:S0163-4453(23)00204-9. doi: 10.1016/j.jinf.2023.
PubMed

SHAW RH, Greenland M, Stuart AS, Aley PK, et al
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
J Infect. 2023 Apr 5:S0163-4453(23)00199-8. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

ZHAO D, Yi H, Dian Y, Meng Y, et al
Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients.
J Infect. 2023 Apr 3:S0163-4453(23)00200-1. doi: 10.1016/j.jinf.2023.
PubMed

CHEN H, Zhang L, Zhang Y, Chen G, et al
Prevalence and clinical features of long COVID from omicron infection in children and adults.
J Infect. 2023;86:e97-e99.
PubMed

March 2023

GAO Y, Luo Z, Ren S, Duan Z, et al
Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19.
J Infect. 2023 Mar 30:S0163-4453(23)00192-5. doi: 10.1016/j.jinf.2023.
PubMed

KELLENI MT
SARS CoV-2 Genetic Jump to a New SARS CoV-3 Pandemic: Let's Be Prepared.
J Infect. 2023 Mar 21:S0163-4453(23)00147-0. doi: 10.1016/j.jinf.2023.
PubMed

NAMGUNG SH, Jung J, Kim SK, Kim EO, et al
Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic.
J Infect. 2023 Mar 21:S0163-4453(23)00146-9. doi: 10.1016/j.jinf.2023.
PubMed

HSU WH, Shiau BW, Tsai YW, Wu JY, et al
The effect of molnupiravir on post-acute outcome of COVID-19 survivors.
J Infect. 2023 Mar 21:S0163-4453(23)00145-7. doi: 10.1016/j.jinf.2023.
PubMed

DANIAL-FARRAN N, Khlaila M, Avraham-Kelbert M, Chazan B, et al
Genetic Variant in Complement Receptor 1 (CR1, CD35) is Associated with A Cluster of Severe Fatal COVID-19 in a Family.
J Infect. 2023 Mar 14:S0163-4453(23)00143-3. doi: 10.1016/j.jinf.2023.
PubMed

CLARK TW, Lindsley K, Wigmosta TB, Bhagat A, et al
Rapid Multiplex PCR for Respiratory Viruses Reduces Time to Result and Improves Clinical Care: Results of a Systematic Review and Meta-Analysis.
J Infect. 2023 Mar 9:S0163-4453(23)00134-2. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

SHAO JW, Zhang XL, Sun J, Liu H, et al
Infection of wild rats with H5N6 subtype highly pathogenic avian influenza virus in China.
J Infect. 2023 Mar 7:S0163-4453(23)00136-6. doi: 10.1016/j.jinf.2023.
PubMed

WANG H, Liu Y, Li P, Liu C, et al
Emergence of epidemic variants of SARS-CoV-2 by acquiring combinations of new highly mutable nucleotides in its genome.
J Infect. 2023 Mar 6:S0163-4453(23)00133-0. doi: 10.1016/j.jinf.2023.
PubMed

QUILES-JIMENEZ A, Sousa M, Huse C, Dyrhol-Riise AM, et al
Severely-ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome.
J Infect. 2023 Mar 6:S0163-4453(23)00132-9. doi: 10.1016/j.jinf.2023.
PubMed

SIVAKUMARAN S, Alsallakh MA, Lyons RA, Quint JK, et al
Estimating the contribution of respiratory pathogens to acute exacerbations of COPD using routine data.
J Infect. 2023;86:233-238.
PubMed Abstract available

LIU P, Xu J
Genomic surveillance of SARS-CoV-2 in mainland China after ending the zero-COVID policy, December 2022 - January 2023.
J Infect. 2023 Mar 1:S0163-4453(23)00127-5. doi: 10.1016/j.jinf.2023.
PubMed

February 2023

SCARPA F, Imperia E, Azzena I, Giovanetti M, et al
Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage.
J Infect. 2023 Feb 28:S0163-4453(23)00126-3. doi: 10.1016/j.jinf.2023.
PubMed

SHAVA E, Izu A, Gaolathe T, Walker A, et al
Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana.
J Infect. 2023 Feb 28:S0163-4453(23)00123-8. doi: 10.1016/j.jinf.2023.
PubMed

DENG Y, Han S, Liu J, Guo L, et al
The risks of death and hospitalizations associated with SARS-CoV-2 Omicron declined after lifting testing and quarantining measures.
J Infect. 2023 Feb 27:S0163-4453(23)00118-4. doi: 10.1016/j.jinf.2023.
PubMed

ZHOU P, Gong F, Ji T, Cao C, et al
Enriched CXCR3(+) CXCR5(+) CD8(+) T cells in SARS-CoV-2 infected and vaccinated individuals effectively respond to the antigen in recall.
J Infect. 2023 Feb 23:S0163-4453(23)00109-3. doi: 10.1016/j.jinf.2023.
PubMed

GUO H, Zhao T
Multiple mutations of IFITM3 are associated with COVID-19 susceptibility.
J Infect. 2023 Feb 23:S0163-4453(23)00120-2. doi: 10.1016/j.jinf.2023.
PubMed

YANG F, Zhang N, Meng R, Wang K, et al
Non-causal Association of COVID-19 with Systemic Lupus Erythematosus: Evidence from a Bidirectional Mendelian RandomizationRunning title: Association of COVID-19 with SLE.
J Infect. 2023 Feb 21:S0163-4453(23)00115-9. doi: 10.1016/j.jinf.2023.
PubMed

UELAND T, Aikas LAO, Dahl TB, Gregersen I, et al
Low-Density Lipoprotein Particles Carrying Proinflammatory Proteins with Altered Aggregation Pattern Detected in COVID-19 Patients 3 Months After HospitalizationRunning title: Low-Density Lipoprotein Particles in COVID-19 Patients.
J Infect. 2023 Feb 21:S0163-4453(23)00111-1. doi: 10.1016/j.jinf.2023.
PubMed

PUTRI DU, Huang CK, Ou TY, Lin CF, et al
Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestationRunning title: Occult post-COVID immune dysregulation.
J Infect. 2023 Feb 21:S0163-4453(23)00112-3. doi: 10.1016/j.jinf.2023.
PubMed

ZHANG K, Chen R, Jiang Q
Allopurinol Increased the Risk of COVID-19 Hospitalization Mediated by E-Selectin Downregulation.
J Infect. 2023 Feb 21:S0163-4453(23)00116-0. doi: 10.1016/j.jinf.2023.
PubMed

MEI R, Kwok SLL, Lau EHY, Lo THK, et al
Battle of Polio eradication in the Western Pacific Region in the transition to COVID-19 endemicity.
J Infect. 2023 Feb 21:S0163-4453(23)00113-5. doi: 10.1016/j.jinf.2023.
PubMed

WAN EYF, Wang B, Mathur S, Chan CIY, et al
Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase.
J Infect. 2023 Feb 21:S0163-4453(23)00117-2. doi: 10.1016/j.jinf.2023.
PubMed

VALENTINI D, Carfi A, Di Paola A, Yarci-Carrion A, et al
Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: data from an international, collaborative initiative of the Trisomy 21 Research SocietyRUNNING TITLE: Factors determining COVID-19 vaccine
J Infect. 2023 Feb 20:S0163-4453(23)00090-7. doi: 10.1016/j.jinf.2023.
PubMed

POWELL AA, Ireland G, Leeson R, Lacey A, et al
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021.
J Infect. 2023 Feb 15:S0163-4453(23)00085-3. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

BIRD PW, Pan D, Martin CA, Gogoi M, et al
Awareness of HIV, Hepatitis B, Hepatitis C, Tuberculosis and COVID-19 in Migrant Students in the UK - A Pilot Survey from an Institute of Higher Education.
J Infect. 2023 Feb 14:S0163-4453(23)00086-5. doi: 10.1016/j.jinf.2023.
PubMed

ZHANG W, Sun M, Zhang P, Liang Y, et al
Epidemiological characteristics of Cytomegalovirus infection in children before and after the COVID-19 pandemic in Henan, China, 2016 - 2022.
J Infect. 2023 Feb 10:S0163-4453(23)00081-6. doi: 10.1016/j.jinf.2023.
PubMed

MENG R, Zhang N, Yang F, Xu Z, et al
Blood Transcriptome Analysis Revealed the Crosstalk Between Severe COVID-19 and Systemic Lupus Erythematosus.
J Infect. 2023 Feb 10:S0163-4453(23)00080-4. doi: 10.1016/j.jinf.2023.
PubMed

LI L, Jia R, Zhang Y, Sun H, et al
Changes of parainfluenza virus infection in children before and after the COVID-19 pandemic in Henan, China.
J Infect. 2023 Feb 9:S0163-4453(23)00078-6. doi: 10.1016/j.jinf.2023.
PubMed

HSU WH, Tsai YW, Wu JY, Liu TH, et al
Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors.
J Infect. 2023 Feb 9:S0163-4453(23)00076-2. doi: 10.1016/j.jinf.2023.
PubMed

EVANS A, Qi C, Adebayo JO, Underwood J, et al
Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study.
J Infect. 2023 Feb 9:S0163-4453(23)00082-8. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

LI L, Song X, Sun H, Ma J, et al
Changes of pathogen distribution in children with wound infections before and after the COVID-19 pandemic in Henan, China.
J Infect. 2023 Feb 9:S0163-4453(23)00079-8. doi: 10.1016/j.jinf.2023.
PubMed

HU S, Zhang S, You Y, Tang J, et al
Olfactory dysfunction after COVID-19; metanalysis reveals persistence in one third of patients six months after initial infection.
J Infect. 2023 Feb 9:S0163-4453(23)00068-3. doi: 10.1016/j.jinf.2023.
PubMed

LI R, Wang M, Li D, Zhang Y, et al
The impact of the COVID-19 pandemic on the number of hand, foot, and mouth disease due to enterovirus 71 infections.
J Infect. 2023 Feb 8:S0163-4453(23)00075-0. doi: 10.1016/j.jinf.2023.
PubMed

CAILLARD S, Laugel E, Benotmane I, Kremer SF, et al
Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding.
J Infect. 2023 Feb 8:S0163-4453(23)00070-1. doi: 10.1016/j.jinf.2023.
PubMed

GRAY EJ, Nguyen-Van-Tam JS
Molnupiravir for SARS-CoV-2 infection: Public health and policy implications.
J Infect. 2023;86:121-122.
PubMed

January 2023

AMANO M, Ichikawa Y, Uemura Y, Matsumoto S, et al
Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines.
J Infect. 2023 Jan 31:S0163-4453(23)00066-X. doi: 10.1016/j.jinf.2023.
PubMed

LIANG J, Liu R, He W, Zeng Z, et al
70% COVID-19 infection within three weeks in the population of Macao, China.
J Infect. 2023 Jan 30:S0163-4453(23)00035-X. doi: 10.1016/j.jinf.2023.
PubMed

CHANG YH, Liu TH, Wu JY, Lai CC, et al
The association between corticosteroids and aspergillosis among COVID-19 patients.
J Infect. 2023 Jan 27:S0163-4453(23)00055-5. doi: 10.1016/j.jinf.2023.
PubMed

RANA MS, Usman M, Alam MM, Tahir M, et al
The emergence of Mumps after the COVID-19 Pandemic in Pakistan: time to consider MMR vaccination strategies.
J Infect. 2023 Jan 26:S0163-4453(23)00057-9. doi: 10.1016/j.jinf.2023.
PubMed

NISAR MI, Ansari N, Malik AA, Shahid S, et al
Assessing the effectiveness of COVID-19 vaccines in Pakistan: a test-negative case-control study.
J Infect. 2023 Jan 25:S0163-4453(23)00021-X. doi: 10.1016/j.jinf.2023.
PubMed

HANI E, Bertran M, Powell A, Williams H, et al
Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: active, prospective national surveillance, January-March 2022, England.
J Infect. 2023 Jan 24:S0163-4453(23)00037-3. doi: 10.1016/j.jinf.2023.
PubMed

GENTRY CA, Nguyen P, Thind SK, Kurdgelashvili G, et al
Characteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.
J Infect. 2023 Jan 23:S0163-4453(23)00023-3. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

KELLENI MT
Evolution of SARS CoV-2 Omicron Subvariants BF.7 and XBB.1.5: Time to follow Africa and abort all COVID Restrictions.
J Infect. 2023 Jan 23:S0163-4453(23)00030-0. doi: 10.1016/j.jinf.2023.
PubMed

WU JY, Liu TH, Huang PY, Tsai YW, et al
The effect of zinc on the outcome of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.
J Infect. 2023 Jan 21:S0163-4453(23)00028-2. doi: 10.1016/j.jinf.2023.
PubMed

ZHAN H, Yang L, Liu Y, Li H, et al
Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis.
J Infect. 2023 Jan 21:S0163-4453(23)00034-8. doi: 10.1016/j.jinf.2023.
PubMed

LIU X, Lv Z, Wang J, Zhou Y, et al
IL1RA Mediated the Effects of Aspirin on Covid-19 severity: a Mendelian Randomization Study.
J Infect. 2023 Jan 20:S0163-4453(23)00031-2. doi: 10.1016/j.jinf.2023.
PubMed

LIANG Y, Hou L, Hou G, Zhang X, et al
The influences of the COVID-19 pandemic on Epstein-Barr virus infection in children, Henan, China.
J Infect. 2023 Jan 20:S0163-4453(23)00026-9. doi: 10.1016/j.jinf.2023.
PubMed

SALTO-ALEJANDRE S, Carretero-Ledesma M, Camacho-Martinez P, Berastegui-Cabrera J, et al
Serum IFN-gamma and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients.
J Infect. 2023 Jan 20:S0163-4453(23)00024-5. doi: 10.1016/j.jinf.2023.
PubMed

KANG SW, Kim JW, Kim JY, Lim SY, et al
Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study.
J Infect. 2023 Jan 19:S0163-4453(23)00029-4. doi: 10.1016/j.jinf.2023.
PubMed

RANA MS, Usman M, Alam MM, Tahir M, et al
Changes in the prevalence of infectious diseases before and after the COVID-19 pandemic in Pakistan.
J Infect. 2023 Jan 19:S0163-4453(23)00025-7. doi: 10.1016/j.jinf.2023.
PubMed

RU X, Chen S, Zhang T, Ding Z, et al
Nonpharmaceutical intervention is an effective measure to block respiratory virus coinfections with SARS-CoV-2.
J Infect. 2023 Jan 18:S0163-4453(23)00018-X. doi: 10.1016/j.jinf.2023.
PubMed

SHAH RA, Mentzer AJ, James T, Cox S, et al
A novel near-patient host-protein score predicts COVID-19 deterioration at presentation to secondary care.
J Infect. 2023 Jan 18:S0163-4453(23)00022-1. doi: 10.1016/j.jinf.2023.
PubMed

KANG SW, Park H, Kim JY, Lim SY, et al
Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study.
J Infect. 2023 Jan 18:S0163-4453(23)00020-8. doi: 10.1016/j.jinf.2023.
PubMed

LIU TH, Wu JY, Huang PY, Tsai YW, et al
The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients.
J Infect. 2023 Jan 14:S0163-4453(23)00017-8. doi: 10.1016/j.jinf.2023.
PubMed

REACHER M, Warne B, Verlander NQ, Popay A, et al
Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,064 patients hospitalised during the 2016-17 and 2017-18 influenza seasons.
J Infect. 2023 Jan 13:S0163-4453(23)00003-8. doi: 10.1016/j.jinf.2023.
PubMed Abstract available

LI X, Li T, Chen N, Kang P, et al
Changes of Mycoplasma pneumoniae infection in children before and after COVID-19 pandemic in Henan, China.
J Infect. 2023 Jan 13:S0163-4453(23)00012-9. doi: 10.1016/j.jinf.2022.
PubMed

TSAI YW, Tsai CF, Wu JY, Huang PY, et al
The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network.
J Infect. 2023 Jan 9:S0163-4453(23)00007-5. doi: 10.1016/j.jinf.2023.
PubMed

DING X, Liang H, Qi X, Sun G, et al
Changes of Klebsiella pneumoniae infection and carbapenem resistance in ICU elderly infected patients before and after the COVID-19 pandemic in Zhengzhou, China.
J Infect. 2023 Jan 9:S0163-4453(23)00009-9. doi: 10.1016/j.jinf.2023.
PubMed

XU J, Wang Y, Duan G, Liu F, et al
Impact of non-pharmaceutical interventions during COVID-19 pandemic on measles and mumps in mainland China.
J Infect. 2023 Jan 9:S0163-4453(23)00008-7. doi: 10.1016/j.jinf.2023.
PubMed

PATIL S, Chen H, Dong S, Liu S, et al
Klebsiella pneumoniae infection in the paediatric population before and after the COVID-19 pandemic in Shenzhen, China.
J Infect. 2023 Jan 8:S0163-4453(23)00004-X. doi: 10.1016/j.jinf.2023.
PubMed

LI Y, Liang H, Ding X, Cao Y, et al
Effectiveness of COVID-19 vaccine in children and adolescents with the Omicron variant: A systematic review and meta-analysis.
J Infect. 2023 Jan 6:S0163-4453(23)00001-4. doi: 10.1016/j.jinf.2023.
PubMed

YU Z, Xu S, Li L, Li M, et al
Changes of Cytomegalovirus infection in neonates before and after the COVID19 pandemic in Zhengzhou, China.
J Infect. 2023 Jan 5:S0163-4453(23)00002-6. doi: 10.1016/j.jinf.2023.
PubMed

ZHAO S, Sha T, Xue Y, Chen H, et al
Flattening the Curve is Imperative: When China Relaxes the Dynamic Zero COVID-19 Policy.
J Infect. 2023 Jan 2:S0163-4453(22)00748-4. doi: 10.1016/j.jinf.2022.
PubMed

PEGORARO F, Barbati F, Pisano L, Moriondo M, et al
Pre-admission RT-qPCR based RSV screening reduces nosocomial RSV infections during epidemic outbreaks.
J Infect. 2023;86:66-117.
PubMed

HIROTSU Y, Omata M
Detection of the Omicron BA.2.75 subvariant in Japan.
J Infect. 2023;86:e5-e7.
PubMed

XIA J, Zhu Y, Bi H, Wu X, et al
Respiratory virus infections among hospitalized children aged 7 years and younger in Wuhan, China, 2017-2021.
J Infect. 2023;86:e1-e4.
PubMed

CAMACHO J, Zulaica J, Gimenez E, Rusu L, et al
Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naive individuals in the general population.
J Infect. 2023 Jan 1:S0163-4453(22)00755-1. doi: 10.1016/j.jinf.2022.
PubMed

December 2022

CILLONIZ C, Motos A, Castaneda T, Gabarrus A, et al
Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study.
J Infect. 2022 Dec 31:S0163-4453(22)00753-8. doi: 10.1016/j.jinf.2022.
PubMed

LIANG Y, Li J, Hou L, Zhang X, et al
Changes of Staphylococcus aureus infection in children before and after the COVID-19 pandemic, Henan, China.
J Infect. 2022 Dec 28:S0163-4453(22)00751-4. doi: 10.1016/j.jinf.2022.
PubMed

FERNANDEZ-DE-LAS-PENAS C, Arendt-Nielsen L, Diaz-Gil G, Gil-Crujera A, et al
ACE1 rs1799752 Polymorphism is not Associated with Long-COVID Symptomatology in Previously Hospitalized COVID-19 Survivors.
J Infect. 2022 Dec 27:S0163-4453(22)00752-6. doi: 10.1016/j.jinf.2022.
PubMed

LI Y, Cao Y, Ding X, Yang D, et al
Influence of the COVID-19 pandemic on Staphylococcus aureus bloodstream infection in children, Henan, China.
J Infect. 2022 Dec 25:S0163-4453(22)00746-0. doi: 10.1016/j.jinf.2022.
PubMed

SCHILDGEN O, Lusebrink J, Schildgen V
Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way out.
J Infect. 2022 Dec 24:S0163-4453(22)00744-7. doi: 10.1016/j.jinf.2022.
PubMed

KRONE M, Wagenhauser I, Knies K, Hofmann D, et al
Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents.
J Infect. 2022 Dec 21:S0163-4453(22)00740-X. doi: 10.1016/j.jinf.2022.
PubMed

JANKUNAS R, Sakalauskas L, Zamaryte-Sakaviciene K, Stakisaitis D, et al
COMMENTARY ON THE IMPACT OF THE COVID-19 PASSPORTS IN LITHUANIA.
J Infect. 2022 Dec 20:S0163-4453(22)00703-4. doi: 10.1016/j.jinf.2022.
PubMed

C O, H W, R B, E L, et al
Following the Omicron wave, the majority of children in England have evidence of previous COVID infection.
J Infect. 2022 Dec 18:S0163-4453(22)00701-0. doi: 10.1016/j.jinf.2022.
PubMed

LI X, Peng K, Cheng FW, Lam DC, et al
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).
J Infect. 2022 Dec 17:S0163-4453(22)00706-X. doi: 10.1016/j.jinf.2022.
PubMed

ZHANG M, Gao J, Guo Q, Zhang X, et al
Changes of respiratory syncytial virus infection in children before and after the COVID-19 pandemic in Henan, China.
J Infect. 2022 Dec 15:S0163-4453(22)00702-2. doi: 10.1016/j.jinf.2022.
PubMed

LIANG Y, Zhang P, Du B, Zhang X, et al
Changes of Mycoplasma pneumoniae infection in children before and after the COVID - 19 pandemic, Henan, China.
J Infect. 2022 Dec 15:S0163-4453(22)00705-8. doi: 10.1016/j.jinf.2022.
PubMed

SUN J, Wang N, Jiang Z, Li D, et al
Are companion animals overlooked intermediate hosts for the cross-species transmission of influenza viruses?
J Infect. 2022 Dec 12:S0163-4453(22)00695-8. doi: 10.1016/j.jinf.2022.
PubMed

LI L, Ma J, Guo P, Gao K, et al
Changes of coagulase-negative Staphylococci infections in children before and after the COVID-19 pandemic in Zhengzhou, China.
J Infect. 2022 Dec 12:S0163-4453(22)00698-3. doi: 10.1016/j.jinf.2022.
PubMed

XU J, Wang Y, Liu F, Yang H, et al
Changes of tuberculosis infection in mainland China before and after the COVID-19 pandemic.
J Infect. 2022 Dec 11:S0163-4453(22)00699-5. doi: 10.1016/j.jinf.2022.
PubMed

KELLENI MT
Real-life Practice of the Egyptian Kelleni's Protocol in the Current Tripledemic: COVID-19, RSV and Influenza.
J Infect. 2022 Dec 10:S0163-4453(22)00697-1. doi: 10.1016/j.jinf.2022.
PubMed

CHENG P, Li L, Sun H, Zhu C, et al
Changes of pathogen distribution in children with bacterial meningitis before and after the COVID-19 pandemic in Zhengzhou, China.
J Infect. 2022 Dec 10:S0163-4453(22)00696-X. doi: 10.1016/j.jinf.2022.
PubMed

HANNAWI S, Safeldin L, Abuquta A, Alamadi A, et al
Safety and Immunogenicity of a Bivalent SARS-CoV-2 Protein Booster Vaccine, SCTV01C in Adults Previously Vaccinated with Inactivated Vaccine: A Randomized, Double-blind, Placebo-controlled Phase 1/2 Clinical Trial.
J Infect. 2022 Dec 9:S0163-4453(22)00693-4. doi: 10.1016/j.jinf.2022.
PubMed

POZO-BALADO MDM, Ramos A, Rodriguez VG, Martinez IO, et al
LONGITUDINAL AGE DIFFERENCES IN HUMORAL RESPONSES TO THE BNT162b2 VACCINE IN THE ELDERLY ARE LOST AFTER THE THIRD DOSE.
J Infect. 2022 Dec 8:S0163-4453(22)00692-2. doi: 10.1016/j.jinf.2022.
PubMed

LIANG Y, Qin X, Hou G, Zhang X, et al
Changes of Moraxella catarrhalis infection in children before and after the COVID-19 pandemic, Zhengzhou, China.
J Infect. 2022 Dec 6:S0163-4453(22)00691-0. doi: 10.1016/j.jinf.2022.
PubMed

LI L, Yu Z, Li M, Sun H, et al
Changes of Acinetobacter baumannii infections in children before and after the COVID-19 pandemic in Zhengzhou, China.
J Infect. 2022 Dec 2:S0163-4453(22)00689-2. doi: 10.1016/j.jinf.2022.
PubMed

LI K, Wang D, Qu H, Rui J, et al
Viral Dynamics of Omicron BA.2.76 Variant of SARS-CoV-2 in a Cohort of COVID-19 Patients.
J Infect. 2022 Dec 2:S0163-4453(22)00688-0. doi: 10.1016/j.jinf.2022.
PubMed

KAKIMOTO M, Miyamori D, Omori K, Kobayashi T, et al
Impact of the early phase of COVID-19 on the trends of isolated bacteria in the national database of Japan: an interrupted time-series analysis.
J Infect. 2022 Dec 1:S0163-4453(22)00686-7. doi: 10.1016/j.jinf.2022.
PubMed Abstract available

CHEEMA HA, Shafiee A, Athar MMT, Shahid A, et al
No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis.
J Infect. 2022 Dec 1:S0163-4453(22)00683-1. doi: 10.1016/j.jinf.2022.
PubMed

JIANG L, Tang L, Zhu L, Zhu Y, et al
Viral dynamics during SARS-CoV-2 omicron infection highlight presymptomatic and asymptomatic infectiousness.
J Infect. 2022 Dec 1:S0163-4453(22)00687-9. doi: 10.1016/j.jinf.2022.
PubMed

November 2022

TANG Y, Dang X, Lv M, Norris SL, et al
Changes in the prevalence of respiratory pathogens in children due to the COVID-19 pandemic: a systematic review and meta-analysis.
J Infect. 2022 Nov 29:S0163-4453(22)00685-5. doi: 10.1016/j.jinf.2022.
PubMed

DENG YK, Shi KT, Liu Z, Zeng M, et al
Persistent olfactory dysfunction 2 years after onset of COVID-19.
J Infect. 2022 Nov 29:S0163-4453(22)00684-3. doi: 10.1016/j.jinf.2022.
PubMed

LV L, Li A, Jiang L, Zhang L, et al
Deficiency of HTR4 and ADRB1 caused by SARS-CoV-2 spike may partially explain multiple COVID-19 related syndromes including depression, cognitive impairment, loss of appetite, heart failure, and hypertension.
J Infect. 2022 Nov 28:S0163-4453(22)00682-X. doi: 10.1016/j.jinf.2022.
PubMed

CHEN D, Pan Y, Wang Y, Chen X, et al
Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies.
J Infect. 2022 Nov 26:S0163-4453(22)00673-9. doi: 10.1016/j.jinf.2022.
PubMed

ZHENG M
China plans to strike a balance between socio-economic development and anti-COVID-19 policy: report from the 20th National Congress of China.
J Infect. 2022 Nov 25:S0163-4453(22)00680-6. doi: 10.1016/j.jinf.2022.
PubMed

TRKULJA V
There is no reasonable evidence to support efficacy of fluvoxamine in prevention of disease deterioration in COVID-19 outpatients: a comment on two recent meta-analyses advocating its use.
J Infect. 2022 Nov 24:S0163-4453(22)00677-6. doi: 10.1016/j.jinf.2022.
PubMed

LI L, Song C, Li P, Li Y, et al
Changes of Escherichia coli infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
J Infect. 2022 Nov 24:S0163-4453(22)00678-8. doi: 10.1016/j.jinf.2022.
PubMed

ZHAO Y, Zhao Y, Zhou Y, Zhang Z, et al
Inactivated COVID-19 vaccination and maternal renal function during early pregnancy: a retrospective cohort study of 6397 Chinese pregnant women.
J Infect. 2022 Nov 22:S0163-4453(22)00676-4. doi: 10.1016/j.jinf.2022.
PubMed

YARCI-CARRION A, Esparcia-Pinedo L, Mateo-Jimenez G, Alfranca A, et al
Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome.
J Infect. 2022 Nov 20:S0163-4453(22)00675-2. doi: 10.1016/j.jinf.2022.
PubMed

ZHOU J, Chen Y, Shao Z, Ding S, et al
Continuing evolution and transmission of avian influenza A(H3N8) viruses is a potential threat to public health.
J Infect. 2022 Nov 17:S0163-4453(22)00651-X. doi: 10.1016/j.jinf.2022.
PubMed

WANG G, Zhao K, Han J, Hu Z, et al
Safety and Immunogenicity of a Bivalent SARS-CoV-2 Recombinant Protein Vaccine, SCTV01C in Unvaccinated Adults: A Randomized, Double-blinded, Placebo-controlled, Phase I Clinical Trial.
J Infect. 2022 Nov 17:S0163-4453(22)00649-1. doi: 10.1016/j.jinf.2022.
PubMed

ROMBAUTS A, Infante C, de Lagos MDAM, Alba J, et al
Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study.
J Infect. 2022 Nov 17:S0163-4453(22)00650-8. doi: 10.1016/j.jinf.2022.
PubMed

MARCEC R, Dodig VM, Likic R
A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference.
J Infect. 2022 Nov 17:S0163-4453(22)00672-7. doi: 10.1016/j.jinf.2022.
PubMed

HOQUE SA, Kotaki T, Pham NTK, Onda Y, et al
Abundance of viral gastroenteritis before and after the emergence of COVID-19: Molecular evidence on wastewater.
J Infect. 2022 Nov 17:S0163-4453(22)00648-X. doi: 10.1016/j.jinf.2022.
PubMed

LI T, Li X, Gao K, Dong G, et al
Changes in pathogen distribution in the blood culture of neonates before and after the COVID-19 pandemic, Henan, China.
J Infect. 2022 Nov 10. pii: S0163-4453(22)00644.
PubMed

HU S, You Y, Zhang S, Tang J, et al
Multidrug-resistant infection in COVID-19 patients: a meta-analysis.
J Infect. 2022 Nov 5. pii: S0163-4453(22)00640.
PubMed

CHEN Y, Fan L, Deng W, Lin Q, et al
Highly Pathogenic Avian Influenza outbreaks amongst bird populations in Europe - a view from China.
J Infect. 2022 Nov 3. pii: S0163-4453(22)00638.
PubMed

MASHIMO Y, Yamazaki K, Kageyama T, Tanaka S, et al
Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine.
J Infect. 2022 Nov 2. pii: S0163-4453(22)00614.
PubMed

MARCEC R, Dodig VM, Likic R
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say?
J Infect. 2022 Nov 1. pii: S0163-4453(22)00627.
PubMed

October 2022

COSTA R, Signes-Costa J, Olea B, Tarraso J, et al
Initial SARS-CoV-2 RNA load in nasopharyngeal specimens is not associated with severity and midterm resolution of pneumonia in COVID-19 patients.
J Infect. 2022 Oct 28. pii: S0163-4453(22)00629.
PubMed

HE WQ, Gianacas C, Muscatello DJ, Newall AT, et al
Effectiveness of influenza vaccination in reducing influenza-like illness and related antibiotic prescriptions in adults from a primary care-based case-control study.
J Infect. 2022 Oct 23. pii: S0163-4453(22)00626.
PubMed Abstract available

KANDEL C, Lee Y, Taylor M, Llanes A, et al
Viral Dynamics of the SARS-CoV-2 Omicron Variant Among Household Contacts with 2 or 3 COVID-19 Vaccine Doses.
J Infect. 2022 Oct 22. pii: S0163-4453(22)00625.
PubMed Abstract available

TIAN J, Li M, Li Y, Bai X, et al
H3N8 subtype avian influenza virus originated from wild birds exhibited dual receptor-binding profiles.
J Infect. 2022 Oct 20. pii: S0163-4453(22)00622.
PubMed Abstract available

SHINGLETON J, Williams H, Oligbu G, Powell A, et al
The changing epidemiology of PIMS-TS across COVID-19 waves: prospective national surveillance, January 2021 to July 2022, England.
J Infect. 2022 Oct 20. pii: S0163-4453(22)00617.
PubMed

GUO Y, Zhang Y, Hu Y
COVID-19 subgroups may slow down biological age acceleration.
J Infect. 2022 Oct 20. pii: S0163-4453(22)00616.
PubMed

ZHOU J, Zhao P, Nie M, Gao K, et al
Changes of Haemophilus influenzae infection in children before and after the COVID-19 pandemic, Henan, China.
J Infect. 2022 Oct 20. pii: S0163-4453(22)00615.
PubMed

NISHIKIMI A, Nakagawa T, Fujiwara M, Watanabe K, et al
Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan.
J Infect. 2022 Oct 20. pii: S0163-4453(22)00621.
PubMed

ZHANG Y, Han S, Yao M, Guo X, et al
Breakthrough Infection shapes humoral immunity against SARS-CoV-2 Omicron Variant.
J Infect. 2022 Oct 20. pii: S0163-4453(22)00620.
PubMed

ZHENG Q, Wang M, Cheng Y, Liu J, et al
Antibody response and safety of COVID-19 vaccine in peritoneal dialysis patients.
J Infect. 2022 Oct 17. pii: S0163-4453(22)00612.
PubMed

NAZARETH J, Barr I, Sullivan SG, Goss C, et al
Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients.
J Infect. 2022 Oct 13. pii: S0163-4453(22)00604.
PubMed

CHEEMA HA, Jafar U, Elrashedy AA, Shahid A, et al
Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: a systematic review and meta-analysis.
J Infect. 2022 Oct 13. pii: S0163-4453(22)00608.
PubMed

WANG B, Yu Y, Yu Y, Wang N, et al
Clinical features and outcomes of hospitalized patients with COVID-19 during the Omicron wave in Shanghai, China.
J Infect. 2022 Oct 11. pii: S0163-4453(22)00466.
PubMed

LEE J, Park S, Kim JY, Lim SY, et al
No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers.
J Infect. 2022 Oct 9. pii: S0163-4453(22)00600.
PubMed

ELFIKY AA, Ibrahim IM, Ibrahim MN, Elshemey WM, et al
Host-cell recognition of SARS-CoV-2 spike receptor binding domain from different variants.
J Infect. 2022 Oct 8. pii: S0163-4453(22)00601.
PubMed

CAI H, Yan J, Wang J, Che X, et al
Efficacy of Paxlovid in patients with acute kidney injury who developed COVID-19.
J Infect. 2022 Oct 8. pii: S0163-4453(22)00562.
PubMed

RAFFERTY H, Cann A, Daunt A, Cooke GS, et al
Changing patterns of clinical presentation of COVID-19 in hospital admissions: a single centre prospective cohort study.
J Infect. 2022 Oct 7. pii: S0163-4453(22)00563.
PubMed

GREGERSEN I, Ueland T, Holter JC, Olsen MB, et al
CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
J Infect. 2022 Oct 7. pii: S0163-4453(22)00559.
PubMed

BERTRAN M, Pereira SMP, Nugawela MD, Stephenson T, et al
The relationship between Post COVID symptoms in young people and their parents.
J Infect. 2022 Oct 7. pii: S0163-4453(22)00560.
PubMed

MEDINA MJ, Nazareth J, Dillon HM, Wighton CJ, et al
Respiratory virus transmission using a novel viral challenge model: An observational cohort study.
J Infect. 2022;85:405-411.
PubMed Abstract available

September 2022

ZHENG Q, Ma P, Wang M, Chen Y, et al
Efficacy and safety of Paxlovid for COVID-19:a meta-analysis.
J Infect. 2022 Sep 30. pii: S0163-4453(22)00557.
PubMed

LIU P, Xu J
Resurgence of influenza virus activity during COVID-19 pandemic in Shanghai, China.
J Infect. 2022 Sep 29. pii: S0163-4453(22)00555.
PubMed

CHANDRA A, Hoeg TB
Lack of correlation between school mask mandates and paediatric Covid-19 cases in a large cohort.
J Infect. 2022 Sep 29. pii: S0163-4453(22)00550.
PubMed Abstract available

LA Y, Hong JY, Lee HS, Lee EH, et al
Increase of Multidrug-Resistant Bacteria After the COVID-19 Pandemic in South Korea: Time-series Analyses of a Long-term Multicenter Cohort.
J Infect. 2022 Sep 29. pii: S0163-4453(22)00556.
PubMed

HUANG J, Xia L, Zhao Y, Wu X, et al
Coronavirus disease 2019 vaccination and live birth outcome after fresh embryo transfer.
J Infect. 2022 Sep 26. pii: S0163-4453(22)00552.
PubMed

AO G, Li A, Wang Y, Tran C, et al
The effect of SARS-CoV-2 double vaccination on the outcomes of hemodialysis patients with COVID-19: a meta-analysis.
J Infect. 2022 Sep 26. pii: S0163-4453(22)00553.
PubMed

YIN Y, Lin J, Yuan S, Tong S, et al
A booster shot of vaccine against SARS-CoV-2 should be rigorously promoted and implemented in China.
J Infect. 2022 Sep 25. pii: S0163-4453(22)00546.
PubMed

CHOI MJ, Choi JY, Hyun H, Nham E, et al
Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: comparison between prior SARS-CoV-2-infected and infection-naive individuals.
J Infect. 2022 Sep 23. pii: S0163-4453(22)00548.
PubMed

YAN F, Gao F
RBD-ACE2 binding properties in five SARS-CoV-2 variants of concern with new perspectives in the design of pan-coronavirus peptide inhibitors.
J Infect. 2022 Sep 14. pii: S0163-4453(22)00541.
PubMed

XU QY, Zheng XQ, Jia ZJ, Wu MJ, et al
Developing new COVID-19 vaccine against the variants is urgently needed rather than boosters: A longitudinal cohort study.
J Infect. 2022 Sep 12. pii: S0163-4453(22)00539.
PubMed

SUN H, Liu H, Liu Y, Pang Z, et al
Genetic characterization of a novel quadruple reassortant influenza A (H1N2) virus from swine, China, 2021.
J Infect. 2022 Sep 10. pii: S0163-4453(22)00538.
PubMed

MOUSSAOUI ME, Desmecht S, Tashkeev A, Lambert N, et al
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naive people living with HIV.
J Infect. 2022 Sep 9. pii: S0163-4453(22)00534.
PubMed

ATTI A, Insalata F, Carr EJ, Otter AD, et al
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: a nested case-control within the SIREN study.
J Infect. 2022 Sep 8. pii: S0163-4453(22)00535.
PubMed Abstract available

WONG LSY, Loo EXL, Huang CH, Yap GC, et al
Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies.
J Infect. 2022 Sep 3. pii: S0163-4453(22)00515.
PubMed

DIMEGLIO C, Tremeaux P, Herin F, Da-Silva I, et al
Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population.
J Infect. 2022 Sep 2. pii: S0163-4453(22)00522.
PubMed

SHI T, Dai M, Liu F, Hu J, et al
Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China.
J Infect. 2022 Sep 2. pii: S0163-4453(22)00521.
PubMed

PATAPNYAN E, Ronen O
Parallel reduction in the prevalence of Bell's palsy, idiopathic sudden sensorineural hearing loss and viral infection diseases during the COVID-19 pandemic.
J Infect. 2022 Sep 2. pii: S0163-4453(22)00518.
PubMed

ZOU P, Li G, Ge X, Wang J, et al
Lymphocyte subset changes in neonates with respiratory syncytial virus pneumonia.
J Infect. 2022;85:334-363.
PubMed

LI P, Niu M, Li Y, Xu M, et al
Human infection with H3N8 avian influenza virus: A novel H9N2-original reassortment virus.
J Infect. 2022 Sep 1. pii: S0163-4453(22)00519.
PubMed

COOPER DJ, Lear S, Watson L, Shaw A, et al
A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital.
J Infect. 2022 Sep 1. pii: S0163-4453(22)00514.
PubMed Abstract available

YIN Y, Lin J, Yuan S, Tong S, et al
The relationship between early isolation and the duration of viral shedding of mild and asymptomatic infection with SARS-CoV-2 Omicron BA.2 variant.
J Infect. 2022 Sep 1. pii: S0163-4453(22)00520.
PubMed

August 2022

LAI CK, Lui GC, Wei Y, Chong KC, et al
Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis.
J Infect. 2022 Aug 31. pii: S0163-4453(22)00513.
PubMed

LINA L, Zhendong G, Sevalie S, Fangfang Z, et al
Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients.
J Infect. 2022 Aug 28. pii: S0163-4453(22)00512.
PubMed

KIM SH, Kyu Cho H, Jeon CH, Sung Ock H, et al
Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia.
J Infect. 2022 Aug 27. pii: S0163-4453(22)00477.
PubMed

GIDARI A, Schiaroli E, Sabbatini S, Bastianelli S, et al
Impact of SARS-CoV-2 Omicron Variants on Serum Neutralization in a Cohort of Healthcare Workers Vaccinated with BNT162b2.
J Infect. 2022 Aug 25. pii: S0163-4453(22)00507.
PubMed

WANG Y, Zheng J, Zhu K, Wang B, et al
The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis.
J Infect. 2022 Aug 25. pii: S0163-4453(22)00506.
PubMed

BAYHAN GI, Korkmaz IO, Seyda E, Tekeli N, et al
Are SARS-CoV-2 viral loads in children lower than in adults?
J Infect. 2022 Aug 24. pii: S0163-4453(22)00509.
PubMed

MIZOUE T, Yamamoto S, Konishi M, Oshiro Y, et al
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.
J Infect. 2022 Aug 19. pii: S0163-4453(22)00480.
PubMed

WANG Y, Chen X, Xiao W, Zhao D, et al
Rapid COVID-19 rebound in a severe COVID-9 patient during 20-day course of Paxlovid.
J Infect. 2022 Aug 19. pii: S0163-4453(22)00478.
PubMed

NOLASCO S, Vitale F, Geremia A, Tramuto F, et al
First case of monkeypox virus, SARS-CoV-2 and HIV co-infection.
J Infect. 2022 Aug 19. pii: S0163-4453(22)00479.
PubMed

WAN EYF, Mok AHY, Yan VKC, Wang B, et al
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.
J Infect. 2022 Aug 16. pii: S0163-4453(22)00472.
PubMed

GOMEZ-CARBALLA A, Martinon-Torres F, Salas A
Is SARS-CoV-2 an oncogenic virus?
J Infect. 2022 Aug 9. pii: S0163-4453(22)00469.
PubMed

CHANG YC, Hsiao CT, Chen WL, Su YD, et al
BioFire FilmArray Respiratory Panel RP2.1 for SARS-CoV-2 detection: The pitfalls.
J Infect. 2022 Aug 8. pii: S0163-4453(22)00468.
PubMed

AIELLO TF, Puerta-Alcalde P, Chumbita M, Monzo P, et al
Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19.
J Infect. 2022 Aug 5. pii: S0163-4453(22)00461.
PubMed

BASSETTI M, Zuccaro V, Asperges E, Scudeller L, et al
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, nonneutropenic, adult patients: an update including COVID-19 data.
J Infect. 2022 Aug 4. pii: S0163-4453(22)00465.
PubMed

AO Y, Li J, Wei Z, Wang Z, et al
Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China.
J Infect. 2022 Aug 4. pii: S0163-4453(22)00462.
PubMed

July 2022

NOH JY, Cheong HJ, Kim WJ, Choi JY, et al
Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination: Running title: Optimal vaccination interval and ceiling effect.
J Infect. 2022 Jul 31. pii: S0163-4453(22)00456.
PubMed

BOJKOVA D, Stack R, Rothenburger T, Kandler JD, et al
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.
J Infect. 2022 Jul 30. pii: S0163-4453(22)00455.
PubMed

DZINAMARIRA T, Moyo E, Moyo P, Pierre G, et al
Childhood immunization services accessibility and utilization during the COVID-19 pandemic in Africa.
J Infect. 2022 Jul 29. pii: S0163-4453(22)00445.
PubMed

MURPHY SL, Halvorsen B, Barratt-Due A, Am DR, et al
Remdesivir modifies interferon response in hospitalized COVID-19 patients.
J Infect. 2022 Jul 29. pii: S0163-4453(22)00450.
PubMed

PASCARELLA S, Ciccozzi M, Benvenuto D, Borsetti A, et al
Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages.
J Infect. 2022 Jul 28. pii: S0163-4453(22)00426.
PubMed

LINA L, Fangfang Z, Sevalie S, Dawei Z, et al
Characteristics of SARS-CoV-2 exhaled by COVID-19 patients.
J Infect. 2022 Jul 28. pii: S0163-4453(22)00424.
PubMed

LI M, Luo Q, Gong C, Li AH, et al
Prospective Surveillance of Human Adenovirus in Acute Respiratory Infections Reveals Epidemiological Features and the Disappearance of Species B During the COVID-19 Pandemic in Beijing, China.
J Infect. 2022 Jul 22. pii: S0163-4453(22)00423.
PubMed

FU J, Luo Y, Fang X, Lu J, et al
Genetic variation of Golgi membrane protein 1 is associated with COVID-19 disease.
J Infect. 2022 Jul 22. pii: S0163-4453(22)00420.
PubMed

VELLAS C, Kamar N, Izopet J
Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment.
J Infect. 2022 Jul 22. pii: S0163-4453(22)00422.
PubMed

HUANG L
Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis.
J Infect. 2022 Jul 14. pii: S0163-4453(22)00418.
PubMed

HAGIYA H, Hikita T, Habu T, Asada M, et al
Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people.
J Infect. 2022 Jul 11. pii: S0163-4453(22)00413.
PubMed

KHANNA R, Htun HL, Lianjie AL, Kyaw WM, et al
Staff and patient surveillance in hospitals: good sentinels for the emergence of new SARS-CoV-2 variants.
J Infect. 2022 Jul 7. pii: S0163-4453(22)00411.
PubMed

VERA-LISE I, Dominik E, Elisabeth R, Kerstin H, et al
"Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants".
J Infect. 2022 Jul 7. pii: S0163-4453(22)00412.
PubMed

LI M, Yu T
Statistical concern on evaluating the consistency between gargle samples and nasopharyngeal (NP) swabs in RT-qPCR-based mass screening approach for the diagnosis of COVID-19.
J Infect. 2022 Jul 6. pii: S0163-4453(22)00408.
PubMed

MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
J Infect. 2022 Jul 5. pii: S0163-4453(22)00406.
PubMed

YAN Y, Davgadorj C, Lyu C, Zhang S, et al
Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
PubMed

GAO X, Zhang S, Gou J, Wen Y, et al
Spike-mediated ACE2 down-regulation involved in the pathogenesis of SARS-CoV-2 infection.
J Infect. 2022 Jul 3. pii: S0163-4453(22)00404.
PubMed Abstract available

LUO Q, Li M, Li A, Gong C, et al
Genetic diversity and epidemiological features of respiratory syncytial virus, Beijing, 2015-2019: A multicenter and all-age groups study.
J Infect. 2022;85:75-85.
PubMed Abstract available

YUAN W, Hou Y, Lin Q, Chen L, et al
How China responds to Omicron.
J Infect. 2022;85:90-122.
PubMed

WEN F, Zhang X, Guo J, Liang Z, et al
Emergence of H3N8 avian influenza viruses possessing tri-basic hemagglutinin cleavage sites in China.
J Infect. 2022 Jul 1. pii: S0163-4453(22)00383.
PubMed

YANG M, Li A, Wang Y, Tran C, et al
Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: a meta-analysis.
J Infect. 2022 Jul 1. pii: S0163-4453(22)00384.
PubMed

June 2022

CARBONELL R, Urgeles S, Salgado M, Rodriguez A, et al
NEGATIVE PREDICTIVE VALUE OF PROCALCITONIN TO RULE OUT BACTERIAL RESPIRATORY CO-INFECTION IN CRITICAL COVID-19 PATIENTS.
J Infect. 2022 Jun 30. pii: S0163-4453(22)00380.
PubMed Abstract available

SACERDOTE C, Milani L, Castiglione A, Pagano E, et al
Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: an Italian cohort study.
J Infect. 2022 Jun 30. pii: S0163-4453(22)00379.
PubMed

O'MORAIN N, Stack R, Doherty J, Tosetto M, et al
Research Letter: Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
J Infect. 2022 Jun 26. pii: S0163-4453(22)00372.
PubMed

REN Y, Liu Y, Zhang Z, Liu Y, et al
SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19.
J Infect. 2022 Jun 26. pii: S0163-4453(22)00377.
PubMed

FOURGEAUD J, Toubiana J, Chappuy H, Delacourt C, et al
No durable impact of COVID-19 measures on the hospital burden of Respiratory Syncytial Virus (France, 2018-2022).
J Infect. 2022 Jun 24. pii: S0163-4453(22)00375.
PubMed

RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al
Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.
J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.
PubMed

YANG M, Li A, Jiang L, Wang Y, et al
Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis.
J Infect. 2022 Jun 18. pii: S0163-4453(22)00369.
PubMed

NIYOMNAITHAM S, Toh ZQ, Licciardi PV, Wongprompitak P, et al
Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial.
J Infect. 2022 Jun 18. pii: S0163-4453(22)00370.
PubMed

PENG H, Wu X, Xiong S, Li C, et al
Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization analysis.
J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.
PubMed

HATCHER J, Gil E, Storey N, Brown JR, et al
Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.
PubMed

COCHINO AV, Farkas OM, Ioan A
Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.
J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.
PubMed

LAZARUS R, Taucher C, Brown C, Corbic I, et al
Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
PubMed Abstract available

COULSON JM, Adams A, Gray LA, Evans A, et al
COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy.
J Infect. 2022 Jun 16. pii: S0163-4453(22)00363.
PubMed

WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
PubMed

KANG SW, Kim JY, Park H, Lim SY, et al
Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
PubMed

GABBI C, Renieri A, Strandvik B
Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.
PubMed Abstract available

SANG L, Cheng B, Yu Y, Xi Y, et al
The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence.
J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.
PubMed

XU QY, Li QL, Jia ZJ, Wu MJ, et al
Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study.
J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
PubMed

IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.
J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
PubMed

LV P, Hu B, Hua R, Zhang J, et al
A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern.
J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
PubMed

ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
PubMed

MELLON G, Rouquette A, Fac C, Carton B, et al
SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study.
J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
PubMed

ZHANG Y, Li J, Jiang L, Chen Q, et al
Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
PubMed

GUO Z, Zhao S, Ryu S, Mok CKP, et al
Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
PubMed

STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
EVALUATING THE POTENTIAL IMPACT OF COVID-19 PASSPORTS IN LITHUANIA.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
PubMed

LI Y, Guo Y, Duan Y
Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
PubMed

May 2022

WANG B, Fu J, Lu A, Yang J, et al
Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
J Infect. 2022 May 31. pii: S0163-4453(22)00337.
PubMed

GIANNONE D, Vecchione MB, Czernikier A, Polo ML, et al
SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
J Infect. 2022 May 27. pii: S0163-4453(22)00315.
PubMed

KAMALI Z, Vonk JM, Thio CHL, Vaez A, et al
A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk of severe COVID-19.
J Infect. 2022 May 23. pii: S0163-4453(22)00313.
PubMed

SA R, Isidro J, Borges V, Duarte S, et al
Unravelling the hurdles of a large COVID-19 epidemiological investigation by viral genomics.
J Infect. 2022 May 21. pii: S0163-4453(22)00302.
PubMed Abstract available

SOVIK S, Barrat-Due A, Kasine T, Olasveengen T, et al
Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation.
J Infect. 2022 May 20. pii: S0163-4453(22)00305.
PubMed Abstract available

NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey.
J Infect. 2022 May 20. pii: S0163-4453(22)00307.
PubMed

CHENG D, Dong Y, Wen S, Shi C, et al
A child with acute respiratory distress syndrome caused by avian influenza H3N8 virus.
J Infect. 2022 May 13. pii: S0163-4453(22)00288.
PubMed

LIU L, Fan X, Guan Q, Yu C, et al
Bioavailable testosterone level is associated with COVID-19 severity in female: A sex-stratified Mendelian randomization study.
J Infect. 2022 May 13. pii: S0163-4453(22)00287.
PubMed

WU X, Peng H, Xiong S, Li C, et al
Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer: COVID-19 infection, severity and risk of endometrial cancer.
J Infect. 2022 May 10. pii: S0163-4453(22)00261.
PubMed

VAN GRONINGEN KM, Dao BL, Gounder P
Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county.
J Infect. 2022 May 9. pii: S0163-4453(22)00259.
PubMed

ZHANG YM, Liu XZ, Lin MM, Zan JC, et al
Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients.
J Infect. 2022 May 9. pii: S0163-4453(22)00260.
PubMed

LUCIJANIC M, Cikara T, Bistrovic P, Papic I, et al
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.
J Infect. 2022 May 2. pii: S0163-4453(22)00251.
PubMed

FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
Exploring the recovery curves for long-term post-COVID functional limitations on daily living activities: The LONG-COVID-EXP-CM multicenter study.
J Infect. 2022;84:722-746.
PubMed

MARIANI C, Borgonovo F, Capetti AF, Oreni L, et al
Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
J Infect. 2022;84:722-746.
PubMed

WAN Z, Lu R, Zhao Y, Zhang C, et al
Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy.
J Infect. 2022 May 1. pii: S0163-4453(22)00250.
PubMed

April 2022

JIMENEZ D, Martinez-Sanz J, Sainz T, Calvo C, et al
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.
J Infect. 2022 Apr 28. pii: S0163-4453(22)00248.
PubMed Abstract available

HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022.
J Infect. 2022 Apr 28. pii: S0163-4453(22)00247.
PubMed

GIANNITRAPANI L, Augello G, Mirarchi L, Amodeo S, et al
Outcome predictors in SARS-CoV-2 disease (COVID-19): the prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population.
J Infect. 2022 Apr 28. pii: S0163-4453(22)00245.
PubMed

LI A, Zhang L
Reduced incidence of acute pharyngitis and increased incidence of chornic pharyngitis under COVID-19 control strategy in Beijing.
J Infect. 2022 Apr 28. pii: S0163-4453(22)00249.
PubMed

RANA MS, Usman MM, Ikram A, Salman M, et al
The negative impact of the COVID-19 Pandemic on immunization and the positive impact on Polio eradication in Pakistan and Afghanistan. A dismal scenario.
J Infect. 2022 Apr 28. pii: S0163-4453(22)00246.
PubMed

YUAN S, Jiang SC, Zhang ZW, Fu YF, et al
Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant.
J Infect. 2022 Apr 23. pii: S0163-4453(22)00215.
PubMed

NGUYEN NN, Houhamdi L, Hoang VT, Stoupan D, et al
High rate of reinfection with the SARS-CoV-2 Omicron variant.
J Infect. 2022 Apr 23. pii: S0163-4453(22)00216.
PubMed

LI Y, Wei L, He L, Sun J, et al
Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
J Infect. 2022 Apr 21. pii: S0163-4453(22)00208.
PubMed Abstract available

HE L, Zeng C, Xu W, Li Y, et al
Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.
J Infect. 2022 Apr 21. pii: S0163-4453(22)00214.
PubMed

AO G, Li A, Wang Y, Tran C, et al
Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis.
J Infect. 2022 Apr 21. pii: S0163-4453(22)00210.
PubMed

CIUFFREDA L, Alcoba-Florez J, Lorenzo-Salazar JM, Gil-Campesino H, et al
Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021.
J Infect. 2022 Apr 21. pii: S0163-4453(22)00212.
PubMed

PANDIT P, Bhatt P, Sahay RR, Joshi Y, et al
A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional.
J Infect. 2022 Apr 18. pii: S0163-4453(22)00205.
PubMed

CAI J, Hu S, Lin Q, Ren T, et al
China's 'dynamic zero COVID-19 strategy' will face greater challenges in the future.
J Infect. 2022 Apr 18. pii: S0163-4453(22)00209.
PubMed

DAVIES J, Gibani MM, Portone G, McGregor A, et al
Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection.
J Infect. 2022 Apr 12. pii: S0163-4453(22)00202.
PubMed

REN Y, Lv L, Li P, Zhang L, et al
Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction.
J Infect. 2022 Apr 11. pii: S0163-4453(22)00201.
PubMed

ZSIGMOND B, Breathnach AS, Mensah A, Ladhani SN, et al
Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England".
J Infect. 2022 Apr 10. pii: S0163-4453(22)00203.
PubMed

WHITAKER H, Tsang RS, Button E, Andrews N, et al
Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
J Infect. 2022 Apr 8. pii: S0163-4453(22)00198.
PubMed Abstract available

LIU X, Munro APS, Feng S, Janani L, et al
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
J Infect. 2022 Apr 8. pii: S0163-4453(22)00200.
PubMed Abstract available

MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study).
J Infect. 2022 Apr 7. pii: S0163-4453(22)00196.
PubMed

BADDAL B, Bostanci A
The impact of COVID-19 on the molecular epidemiology of seasonal viral respiratory infections, Cyprus.
J Infect. 2022 Apr 7. pii: S0163-4453(22)00192.
PubMed

CHENG CY, Hsiao SH, Fang TC, Lin YC, et al
SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients.
J Infect. 2022 Apr 7. pii: S0163-4453(22)00190.
PubMed

YADAV PD, Sahay RR, Agrawal S, Shete A, et al
Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021.
J Infect. 2022 Apr 7. pii: S0163-4453(22)00193.
PubMed

LIU Y, Li P, Yang L, Li P, et al
High vaccination coverage slows down genetic diversity of SARS-CoV-2.
J Infect. 2022 Apr 7. pii: S0163-4453(22)00191.
PubMed

AKBAR S, Pan D, Ehdode A, Islam R, et al
Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19.
J Infect. 2022 Apr 7. pii: S0163-4453(22)00195.
PubMed

ONG JY, Wang CH, Ms YT, Chen FL, et al
Nosocomial septicemia in COVID-19 Nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica Septicemia in a Patient of COVID-19.
J Infect. 2022 Apr 5. pii: S0163-4453(22)00188.
PubMed

SONG W, Yang Y, Huang Y, Chen L, et al
Acute respiratory infections in children, before and after the COVID-19 pandemic, a sentinel study.
J Infect. 2022 Apr 5. pii: S0163-4453(22)00183.
PubMed

GAGNAIRE J, Bonjean P, Verot E, Boulamail B, et al
SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign.
J Infect. 2022 Apr 5. pii: S0163-4453(22)00184.
PubMed

BAEK YJ, Lee YJ, Kim JI, Lee S, et al
Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: a retrospective cohort study.
J Infect. 2022 Apr 5. pii: S0163-4453(22)00186.
PubMed

DUVERGER C, Monteil C, Souyri V, Md SF, et al
Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic.
J Infect. 2022 Apr 1. pii: S0163-4453(22)00179.
PubMed

March 2022

YOON JG, Yoo JS, Lee J, Hyun HJ, et al
Viable SARS-CoV-2 Shedding Under Remdesivir and Dexamethasone Treatment.
J Infect. 2022 Mar 26. pii: S0163-4453(22)00177.
PubMed

MENG J, Ge Q, Li J, Lu X, et al
Protective trend of anti-androgen therapy during the COVID-19 pandemic: a meta-analysis.
J Infect. 2022 Mar 24. pii: S0163-4453(22)00175.
PubMed

SCHILDGEN V, Lusebrink J, Schildgen O
Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnarable individuals.
J Infect. 2022 Mar 23. pii: S0163-4453(22)00173.
PubMed

YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naive vaccinees.
J Infect. 2022 Mar 19. pii: S0163-4453(22)00170.
PubMed

YANG G, Ren Z, Zou Y, Xu Q, et al
Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: lessons from the "dynamic zero-COVID policy" in mainland China.
J Infect. 2022 Mar 18. pii: S0163-4453(22)00141.
PubMed

MURGIA F, Fiamma M, Serra S, Olla S, et al
The impact of secondary infections in COVID-19 critically ill patients.
J Infect. 2022 Mar 18. pii: S0163-4453(22)00171.
PubMed

DIMEGLIO C, Loubes JM, Migueres M, Saune K, et al
Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants.
J Infect. 2022 Mar 17. pii: S0163-4453(22)00140.
PubMed

RYAN P, Perez-Garcia F, Torres-Macho J, Bibiano C, et al
Misdiagnosis rate of among negative COVID-19 patients in real-life with Panbio COVID-19 Antigen Rapid Test during 2021.
J Infect. 2022 Mar 16. pii: S0163-4453(22)00139.
PubMed

AO G, Wang Y, Li A, Tran C, et al
The effect of canakinumab on clinical outcomes in patients with COVID-19: a meta-analysis.
J Infect. 2022 Mar 14. pii: S0163-4453(22)00137.
PubMed

CHEN C, Tang J, Wang C, Wen W, et al
Meta-Analysis of Post-traumatic Stress Disorder and COVID-19 in Patients Discharged.
J Infect. 2022 Mar 10. pii: S0163-4453(22)00134.
PubMed

XIANG B, Yang L, Ye Z, Ren T, et al
Vaccination of Susceptible Animals Against SARS-CoV-2.
J Infect. 2022 Mar 9. pii: S0163-4453(22)00131.
PubMed

BONNET B, Chabrolles H, Archimbaud C, Brebion A, et al
Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.
J Infect. 2022 Mar 9. pii: S0163-4453(22)00132.
PubMed

FERRE VM, Lebourgeois S, Chenane HR, Menidjel R, et al
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
J Infect. 2022 Mar 9. pii: S0163-4453(22)00126.
PubMed

FANTINI J, Devaux CA, Yahi N, Frutos R, et al
The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.
J Infect. 2022 Mar 6. pii: S0163-4453(22)00129.
PubMed

SUN R, Jiang W, Liu S, Peng C, et al
Emergence of Novel Reassortant H5N6 Influenza Viruses in Poultry and Humans in Sichuan Province, China, 2021.
J Infect. 2022 Mar 5. pii: S0163-4453(22)00128.
PubMed

AU WY, Ye C, Briner SL, Suarez GD, et al
Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.
J Infect. 2022 Mar 1. pii: S0163-4453(22)00123.
PubMed

GIMENEZ E, Albert E, Burgos JS, Peiro S, et al
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty(R) COVID-19 vaccine.
J Infect. 2022 Mar 1. pii: S0163-4453(22)00124.
PubMed Abstract available

BONGIOVANNI M, Spada E, De Angelis C, Liuzzi G, et al
SARS-CoV-2: about reinfection, vaccination and neutralizing antibodies.
J Infect. 2022 Mar 1. pii: S0163-4453(22)00125.
PubMed

SYED MA DR, A/Qotba HA Dr, Al Nuaimi AS Dr
Effectiveness of COVID-19 vaccines in Qatar.
J Infect. 2022 Mar 1. pii: S0163-4453(22)00121.
PubMed

February 2022

HAYASHI JY, Simizo A, Miyamoto JG, Costa LVS, et al
Humoral and Cellular Responses to Vaccination with Homologous CoronaVac or ChAdOx1 and Heterologous Third Dose with BNT162b2.
J Infect. 2022 Feb 27. pii: S0163-4453(22)00115.
PubMed

KONIG S, Hohenstein S, Leiner J, Hindricks G, et al
National mortality data for Germany before and throughout the pandemic: there is an excess mortality exceeding COVID-19-attributed fatalities.
J Infect. 2022 Feb 26. pii: S0163-4453(22)00113.
PubMed

SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
J Infect. 2022 Feb 26. pii: S0163-4453(22)00114.
PubMed

PASCARELLA S, Ciccozzi M, Bianchi M, Benvenuto D, et al
The value of electrostatic potentials of the Spike Receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 Variants. of Concern.
J Infect. 2022 Feb 23. pii: S0163-4453(22)00112.
PubMed

DE MICHELENA P, Torres I, Ramos-Garcia A, Gozalbes V, et al
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.
J Infect. 2022 Feb 22. pii: S0163-4453(22)00110.
PubMed

SAHAY RR, Patil DY, Sapkal GN, Deshpande GR, et al
SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera.
J Infect. 2022 Feb 19. pii: S0163-4453(22)00082.
PubMed

TANG K, Wu X, Luo Y, Wei Z, et al
Meta-analysis of Immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients.
J Infect. 2022 Feb 19. pii: S0163-4453(22)00081.
PubMed

LIPPI G, Nocini R, Henry BM
Is SARS-CoV-2 Omicron (B.1.1.529) variant causing different symptoms?
J Infect. 2022 Feb 17. pii: S0163-4453(22)00077.
PubMed

SAEED A, Ahmad B, Majaz S, Nouroz F, et al
Targeting Omicron and other reported SARS-CoV-2 lineages by Potent inhibitors of Main Protease 3CL Mpro: Molecular Simulation Analysis.
J Infect. 2022 Feb 17. pii: S0163-4453(22)00079.
PubMed

ZHENG J, Wang Z, Li J, Zhang Y, et al
High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
J Infect. 2022 Feb 17. pii: S0163-4453(22)00075.
PubMed

KWOK KO, Wei WI, Ma BHM, Ip M, et al
Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.
J Infect. 2022 Feb 17. pii: S0163-4453(22)00078.
PubMed

TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
Assessment 2 months after the administration of a 3rd dose mRNA: A new variant-adapted vaccine is expected.
J Infect. 2022 Feb 15. pii: S0163-4453(22)00073.
PubMed

BLANCO I, Violan C, Suner C, Garcia-Prieto J, et al
Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients.
J Infect. 2022 Feb 13. pii: S0163-4453(22)00072.
PubMed

YADAV PD, Sapkal GN, Sahay RR, Potdar VA, et al
Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns.
J Infect. 2022 Feb 11. pii: S0163-4453(22)00070.
PubMed

RIGHI E, Mirandola M, Mazzaferri F, Dossi G, et al
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study.
J Infect. 2022 Feb 9. pii: S0163-4453(22)00065.
PubMed Abstract available

MIGUERES M, Dimeglio C, Tremeaux P, Abravanel F, et al
Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant.
J Infect. 2022 Feb 7. pii: S0163-4453(22)00054.
PubMed

ZHOU W, Zhong L, Tang X, Huang T, et al
The early warning and monitoring of COVID-19 by using Baidu Search Index in China.
J Infect. 2022 Feb 6. pii: S0163-4453(22)00063.
PubMed

LAZOR-BLANCHET C, Zygoura P, Dafni U, Lamoth F, et al
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
J Infect. 2022 Feb 5. pii: S0163-4453(22)00062.
PubMed

WESTROP SJ, Whitaker HJ, Powell AA, Power L, et al
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England.
J Infect. 2022 Feb 4. pii: S0163-4453(22)00055.
PubMed Abstract available

WU Z, Liu J, Zhang H, Chang YF, et al
The emergence of the novel avian influenza virus (H10N3) in China, 2020-a cause for concern?
J Infect. 2022 Feb 3. pii: S0163-4453(22)00061.
PubMed

CUI H, Liu J, Zhang L
The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients.
J Infect. 2022 Feb 3. pii: S0163-4453(22)00057.
PubMed

DIMEGLIO C, Migueres M, Mansuy JM, Saivin S, et al
Antibody titers and breakthrough infections with Omicron SARS-CoV-2.
J Infect. 2022 Feb 3. pii: S0163-4453(22)00060.
PubMed

KIVIT C, Groen K, Jongbloed M, Linssen C, et al
An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown.
J Infect. 2022 Feb 3. pii: S0163-4453(22)00058.
PubMed

ESTOFOLETE CF, Fares GF, Banho CA, Sacchetto L, et al
Predictors of death in COVID-19 vaccine breakthrough infections in Brazil.
J Infect. 2022 Feb 2. pii: S0163-4453(22)00059.
PubMed

HAVDAL LB, Boas H, Bekkevold T, Kran AB, et al
The burden of respiratory syncytial virus in children under 5 years of age in Norway.
J Infect. 2022;84:205-215.
PubMed Abstract available

LI Z, Tao B, Hu Z, Yi Y, et al
Effects of short-term ambient particulate matter exposure on the risk of severe COVID-19.
J Infect. 2022 Feb 1. pii: S0163-4453(22)00052.
PubMed Abstract available

January 2022

LIVINGSTONE R, Lin H, Brendish NJ, Poole S, et al
Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.
J Infect. 2022 Jan 30. pii: S0163-4453(22)00049.
PubMed Abstract available

XU W, Tang J, Chen C, Wang C, et al
Safety and Efficacy of the Covid-19 Vaccine in children andor adolescents: A meta-analysis.
J Infect. 2022 Jan 30. pii: S0163-4453(22)00050.
PubMed

MATTIUZZI C, Lippi G
COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections.
J Infect. 2022 Jan 30. pii: S0163-4453(22)00051.
PubMed

JI G, Chen C, Zhou M, Wen W, et al
Post-COVID-19 Fatigue among COVID-19 in patients discharged from hospital: A meta-analysis.
J Infect. 2022 Jan 28. pii: S0163-4453(22)00031.
PubMed

MENSAH AA, Lacy J, Stowe J, Seghezzo G, et al
Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study.
J Infect. 2022 Jan 24. pii: S0163-4453(22)00010.
PubMed Abstract available

SCHEPERS M, Zanger P, Jahn K, Konig J, et al
Multi-household social gatherings contribute to the second SARS-CoV-2 wave in Rhineland-Palatinate.
J Infect. 2022 Jan 23. pii: S0163-4453(22)00028.
PubMed Abstract available

RANA MS, Usman MM, Alam MM, Ikram A, et al
Impact of previous SARS-CoV-2 infection on the rate of mortality in dengue. A preliminary report from Pakistan.
J Infect. 2022 Jan 23. pii: S0163-4453(22)00027.
PubMed

GAO R, Xu Y, Zhu G, Zhou S, et al
Genetic variation associated with COVID-19 is also associated with endometrial cancer.
J Infect. 2022 Jan 22. pii: S0163-4453(22)00026.
PubMed

DUCLOUX D, Bamoulid J, Chabannes M, Colladant M, et al
Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients.
J Infect. 2022 Jan 21. pii: S0163-4453(22)00020.
PubMed

MAO Q, Wang C, Zhou M, Wen W, et al
A meta-analysis of the association between calprotectin and the severity of COVID-19.
J Infect. 2022 Jan 21. pii: S0163-4453(22)00023.
PubMed

FAVRESSE J, Bayart JL, David C, Dogne JM, et al
Nucleocapsid Serum Antigen Determination in SARS-CoV-2 Infected Patients Using the Single Molecule Array Technology and Prediction of Disease Severity.
J Infect. 2022 Jan 21. pii: S0163-4453(22)00022.
PubMed

ELFIKY AA, Ibrahim IM
Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view.
J Infect. 2022 Jan 18. pii: S0163-4453(22)00015.
PubMed

ZHANG Y, Jiang N, Qi W, Li T, et al
Intra-host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations.
J Infect. 2022 Jan 15. pii: S0163-4453(22)00017.
PubMed

PILECKY M, Harm S, Bauer C, Zottl J, et al
Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR.
J Infect. 2022 Jan 14. pii: S0163-4453(22)00011.
PubMed

XU Y, Gao R, Zhu G, Zhou S, et al
Genetic variation of allergic disease is associated with the susceptibility to COVID-19.
J Infect. 2022 Jan 14. pii: S0163-4453(22)00016.
PubMed

THANH TT, Nhan NTT, Anh NT, Chung LT, et al
SARS-CoV-2 RNA loads in Vietnamese children.
J Infect. 2022 Jan 13. pii: S0163-4453(22)00012.
PubMed

LIN M, Chen H, Wang Y, Qiu S, et al
A Model Study on Predicting New COVID-19 Cases in China Based on Social and News Media.
J Infect. 2022 Jan 9. pii: S0163-4453(22)00009.
PubMed

CHEN JM, Chen YQ, Sun YX
Control of COVID-19 in China likely reduced the burden of multiple other infectious diseases.
J Infect. 2022 Jan 8. pii: S0163-4453(22)00001.
PubMed

HAN X, Xu P, Wang H, Mao J, et al
Incident changes in the prevalence of respiratory virus among children during COVID-19 pandemic in Hangzhou, China.
J Infect. 2022 Jan 8. pii: S0163-4453(22)00006.
PubMed

FAUSTINI S, Shields A, Banham G, Wall N, et al
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
J Infect. 2022 Jan 8. pii: S0163-4453(22)00002.
PubMed

DE MICHELENA P, Torres I, Albert E, Bracho A, et al
Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.
J Infect. 2022 Jan 8. pii: S0163-4453(22)00007.
PubMed

BORMAN AM, Fountain H, Guy R, Casale E, et al
Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England.
J Infect. 2022 Jan 4. pii: S0163-4453(21)00665.
PubMed

WHITAKER HJ, Tsang RS, Byford R, Andrews NJ, et al
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups.
J Infect. 2022 Jan 3. pii: S0163-4453(21)00664.
PubMed Abstract available

MARRAMS ARM, Kobayashi T, Suzuki H, Alsuhaibani M, et al
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis.
J Infect. 2022 Jan 1. pii: S0163-4453(21)00658.
PubMed Abstract available

December 2021

SIMIONATTO VZ, Evaristo M, Santos EV, Mello R, et al
SARS-CoV-2 SEROLOGICAL CROSS-REACTIVITY TESTING IN BRAZILIAN BLOOD DONORS, OCTOBER-DECEMBER, 2019.
J Infect. 2021 Dec 31. pii: S0163-4453(21)00660.
PubMed

FINCH LS, Harris A, Lester C, Veal D, et al
Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic.
J Infect. 2021 Dec 30. pii: S0163-4453(21)00657.
PubMed Abstract available

KAWAHARA T, Ueki Y, Nawa N, Miyamae S, et al
Who is a super-spreader? Determinants of people with higher PCR copy number of SARS-CoV-2 during Mar 2020 to June 2021 in Japan.
J Infect. 2021 Dec 30. pii: S0163-4453(21)00656.
PubMed

ARORA U, Priyadarshi M, Katiyar V, Soneja M, et al
Novel risk factors for Coronavirus disease-associated mucormycosis(CAM): a case-control study during the outbreak in India.
J Infect. 2021 Dec 30. pii: S0163-4453(21)00654.
PubMed Abstract available

ZENG C, Ye Z, Fu L, Ye Y, et al
Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2.
J Infect. 2021 Dec 30. pii: S0163-4453(21)00655.
PubMed

XU B, Ma FQ, He C, Wu ZQ, et al
Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
J Infect. 2021 Dec 25. pii: S0163-4453(21)00642.
PubMed

VENTERO MP, Moreno-Perez O, Molina-Pardines C, Paytuvi-Gallart A, et al
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
J Infect. 2021 Dec 25. pii: S0163-4453(21)00647.
PubMed Abstract available

LAI X, Wang J, Duan J, Gong Y, et al
Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia.
J Infect. 2021 Dec 23. pii: S0163-4453(21)00640.
PubMed

LI Y, Li P, Xi J, Yang J, et al
Wild bird-origin H3N8 avian influenza virus exhibit well adaptation in mammalian host.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00637.
PubMed

DAVIS W, Duque J, Huang QS, Olson N, et al
Sensitivity and specificity of surveillance case definitions in detection of influenza and respiratory syncytial virus among hospitalized patients, New Zealand, 2012-2016.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00635.
PubMed Abstract available

GENG Y, Zhang L
The impact of non-pharmaceutical interventions during COVID-19 pandemic on three children infectious diseases in China.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00645.
PubMed

MAANI AA, Wahaibi AA, Nazer W, Al-Zadjali N, et al
The utilization of HCWs surveillance as an early warning of COVID-19 epidemic activity in the community.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00629.
PubMed

QIN G, Yang J, Zhao C, Ren J, et al
The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00634.
PubMed

VINER R, Waddington C, Mytton O, Booy R, et al
Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00633.
PubMed Abstract available

SYED-ABDUL S, Babu AS, Bellamkonda RS, Itumalla R, et al
Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from a public hospital in India.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00639.
PubMed Abstract available

COLTELLA L, Ranno S, Piccioni L, Linardos G, et al
Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00636.
PubMed

ORENES-PINERO E, Navas-Carrillo D, Moreno-Docon A, Ortega-Garcia JA, et al
Confirmation of SARS-CoV-2 airborne dissemination indoors using "COVID-19 traps".
J Infect. 2021 Dec 22. pii: S0163-4453(21)00630.
PubMed Abstract available

KHURRAM M, Ali G, Awan UA, Afzal MS, et al
COVID-19 and alarming dengue co-epidemics in the dilapidated healthcare system in Pakistan: Where to focus!
J Infect. 2021 Dec 22. pii: S0163-4453(21)00638.
PubMed

GAO P, Zhang X, Zhang S, Yu Y, et al
COVID-19 persists: Current risk of a recurrence of the epidemic in China.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00643.
PubMed

COSTA R, Olea B, Bracho MA, Albert E, et al
RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00641.
PubMed

YAN F, Gao F
Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00644.
PubMed

RUBESHKUMAR P, John A, Narnaware M, M J, et al
Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021.
J Infect. 2021 Dec 22. pii: S0163-4453(21)00632.
PubMed

WANG R
Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease.
J Infect. 2021 Dec 21. pii: S0163-4453(21)00631.
PubMed

MANOLACHE NG, Ursachi V, Scohy A, Desmet C, et al
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.
J Infect. 2021 Dec 14. pii: S0163-4453(21)00597.
PubMed

OWEN SI, Williams CT, Garrod G, Fraser AJ, et al
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.
J Infect. 2021 Dec 11. pii: S0163-4453(21)00598.
PubMed Abstract available

FANG X, Ming C, Cen Y, Lin H, et al
Post-sequelae one year after hospital discharge among older COVID-19 patients: a multi-center prospective cohort study.
J Infect. 2021 Dec 10. pii: S0163-4453(21)00596.
PubMed Abstract available

MAK WA, Koeleman JGM, van der Vliet M, Keuren F, et al
SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study.
J Infect. 2021 Dec 9. pii: S0163-4453(21)00593.
PubMed Abstract available

QUINTAO TSC, Slavov SN, de Oliveira PM, Bezerra RDS, et al
Viral metagenomics in nasopharyngeal swabs of Brazilian patients negative for SARS-CoV-2 unveils the presence of Chikungunya virus infection.
J Infect. 2021 Dec 5. pii: S0163-4453(21)00585.
PubMed

LUI G, Wong CK, Chan M, Chong KC, et al
Host inflammatory response is the major marker of severe respiratory syncytial virus infection in older adults.
J Infect. 2021;83:686-692.
PubMed Abstract available

November 2021

TANI N, Kawai N, Chong Y, Bando T, et al
Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season.
J Infect. 2021 Nov 30. pii: S0163-4453(21)00583.
PubMed Abstract available

OESER C, Whitaker H, Linley E, Borrow R, et al
Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.
J Infect. 2021 Nov 30. pii: S0163-4453(21)00584.
PubMed

HAN X, Xu J, Hou H, Yang H, et al
Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis.
J Infect. 2021 Nov 29. pii: S0163-4453(21)00582.
PubMed

MENTZER DAJ, James T, Yongya M, Cox S, et al
Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.
J Infect. 2021 Nov 26. pii: S0163-4453(21)00580.
PubMed

ALDERSON MR, Arkwright PD, Bai X, Black S, et al
Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.
J Infect. 2021 Nov 24. pii: S0163-4453(21)00578.
PubMed Abstract available

BEHNOOD SA, Shafran R, Bennett SD, Zhang A, et al
Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies.
J Infect. 2021 Nov 20. pii: S0163-4453(21)00555.
PubMed Abstract available

LEBOURGEOIS S, Menidjel R, Chenane HR, Ferre VM, et al
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
J Infect. 2021 Nov 19. pii: S0163-4453(21)00556.
PubMed

LUO L, Luo T, Du M, Mei H, et al
Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: a systematic review and meta-analysis.
J Infect. 2021 Nov 19. pii: S0163-4453(21)00557.
PubMed

PAN D, Kim JW, Nazareth J, Assadi S, et al
Quantification and prognostic significance of interferon-gamma secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19.
J Infect. 2021 Nov 18. pii: S0163-4453(21)00554.
PubMed

TSAI SC, Chang WW, Lee WS
Analysis of an outbreak of COVID-19(alpha-variant) with rapid progression to mortality in Taipei, Taiwan.
J Infect. 2021 Nov 17. pii: S0163-4453(21)00553.
PubMed

TILLARD C, Chazard E, Faure K, Bartolo S, et al
Burden of influenza disease in children under 2 years of age hospitalized between 2011 and 2020 in France.
J Infect. 2021 Nov 13. pii: S0163-4453(21)00549.
PubMed Abstract available

CHAPPELL H, Patel R, Driessens C, Tarr AW, et al
Immunocompromised children and young people are at no increased risk of severe COVID-19.
J Infect. 2021 Nov 13. pii: S0163-4453(21)00548.
PubMed Abstract available

YAN X, Zhu S, Jin Z, Chen G, et al
Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients.
J Infect. 2021 Nov 13. pii: S0163-4453(21)00550.
PubMed

BEN S, Xin J, Chen S, Jiang Y, et al
Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks.
J Infect. 2021 Nov 9. pii: S0163-4453(21)00546.
PubMed Abstract available

MARTIN-VICENTE M, Berenguer J, Munoz-Gomez MJ, Diez C, et al
Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19: Anti-SARS-CoV-2 S antibodies in PWH.
J Infect. 2021 Nov 6. pii: S0163-4453(21)00545.
PubMed

BURGI JJ, Rosslein M, Hornung H, Jentsch J, et al
Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?: Indication of persistence of SARS-CoV-2?
J Infect. 2021 Nov 5. pii: S0163-4453(21)00544.
PubMed

GIMENEZ E, Alberola J, Torres I, Albert E, et al
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty(R) COVID-19 vaccine.
J Infect. 2021 Nov 2. pii: S0163-4453(21)00542.
PubMed

HESKIN J, Pallett SJC, Mughal N, Jones R, et al
Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: a qualitative analysis across two London hospitals.
J Infect. 2021 Nov 1. pii: S0163-4453(21)00537.
PubMed

October 2021

NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.
J Infect. 2021 Oct 30. pii: S0163-4453(21)00538.
PubMed

WANG J, Zou H, Corpe C
An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.
J Infect. 2021 Oct 30. pii: S0163-4453(21)00536.
PubMed

YE Q, Liu H, Shang S
Non-pharmaceutical interventions reduced the incidence and exacerbation of allergic diseases in children during the COVID-19 pandemic.
J Infect. 2021 Oct 30. pii: S0163-4453(21)00541.
PubMed

LUMLEY SF, Richens N, Lees E, Cregan J, et al
Changes in paediatric respiratory infections at a UK teaching hospital 2016-2021; impact of the SARS-CoV-2 pandemic.
J Infect. 2021 Oct 29. pii: S0163-4453(21)00540.
PubMed Abstract available

LI X, Chen H, Lu L, Chen LL, et al
High compliance to infection control measures prevented guest-to-staff transmission in COVID-19 quarantine hotels.
J Infect. 2021 Oct 26. pii: S0163-4453(21)00533.
PubMed

CHONG Y, Tani N, Goto T, Yonekawa A, et al
Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.
J Infect. 2021 Oct 20. pii: S0163-4453(21)00508.
PubMed

EPAULARD O, Buisson M, Nemoz B, Marechal ML, et al
Persistence at one year of neutralising antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.
J Infect. 2021 Oct 20. pii: S0163-4453(21)00507.
PubMed

GUPTA A, Bhoyar RC, Mirza S, Jolly B, et al
SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.
J Infect. 2021 Oct 19. pii: S0163-4453(21)00506.
PubMed

GUO J, Yu H, Wang C, Yuan S, et al
Re-emergence of Highly Pathogenic Avian Influenza A(H5N8) Virus In Domestic Goose, China.
J Infect. 2021 Oct 17. pii: S0163-4453(21)00504.
PubMed

WANG MH, Lou J, Cao L, Zhao S, et al
Characterization of key amino acid substitutions and dynamics of the influenza virus H3N2 hemagglutinin.
J Infect. 2021 Oct 7. pii: S0163-4453(21)00498.
PubMed Abstract available

BOSHIER FAT, Venturini C, Stirrup O, Guerra-Assuncao JA, et al
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.
J Infect. 2021 Oct 2. pii: S0163-4453(21)00493.
PubMed Abstract available

FERNANDEZ-DE-LAS-PENAS C, Gomez-Mayordomo V, de-la-Llave-Rincon AI, Palacios-Cena M, et al
Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study.
J Infect. 2021;83:496-522.
PubMed

HUMBERT MV, Opurum PC, Brendish NJ, Poole S, et al
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.
J Infect. 2021 Oct 1. pii: S0163-4453(21)00492.
PubMed Abstract available

September 2021

A A, M F, J CO, Ejm M, et al
Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study.
J Infect. 2021 Sep 30. pii: S0163-4453(21)00489.
PubMed Abstract available

LEMENAND O, Coeffic T, Thibaut S, Colomb-Cotinat M, et al
Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.
J Infect. 2021 Sep 29. pii: S0163-4453(21)00486.
PubMed Abstract available

FERRE VM, Lebourgeois S, Menidjel R, Collin G, et al
Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
J Infect. 2021 Sep 29. pii: S0163-4453(21)00488.
PubMed

LECOINTRE L, Venkatasamy A, Wehr M, Koch A, et al
Multicentric evaluation of a 3D-printed simulator for COVID- 19 nasopharyngeal swab collection in testing centers.
J Infect. 2021 Sep 24. pii: S0163-4453(21)00485.
PubMed

DIMEGLIO C, Herin F, Martin-Blondel G, Miedouge M, et al
Antibody titers and protection against a SARS-CoV-2 infection.
J Infect. 2021 Sep 21. pii: S0163-4453(21)00483.
PubMed

MCMILLAN T, Jones C, O'Connor CJ, Nolan D, et al
Risk factors associated with bloodstream infections among critically ill patients with COVID-19.
J Infect. 2021 Sep 16. pii: S0163-4453(21)00480.
PubMed

ALEMANY A, Millat-Martinez P, Ouchi D, Corbacho-Monne M, et al
Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients.
J Infect. 2021 Sep 16. pii: S0163-4453(21)00481.
PubMed

LUNA-MUSCHI A, Borges IC, de Faria E, Barboza AS, et al
Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers.
J Infect. 2021 Sep 16. pii: S0163-4453(21)00474.
PubMed

FANG C, Zhou Z, Li J, Zhou M, et al
Incident changes of rotavirus enteritis among children during the coronavirus disease-2019 pandemic in Hangzhou, China.
J Infect. 2021 Sep 15. pii: S0163-4453(21)00478.
PubMed

AWAN UA, Malik MW, Khan MI, Khattak AA, et al
Predicting COVID-19 incidence in war-torn Afghanistan: A timely response is required!
J Infect. 2021 Sep 15. pii: S0163-4453(21)00473.
PubMed

CHEN H, Zhao X, Li L, Yan S, et al
Mental health and physical symptoms of people quarantined during the COVID-19 outbreak.
J Infect. 2021 Sep 15. pii: S0163-4453(21)00479.
PubMed

ZUO L, Ao G, Wang Y, Gao M, et al
Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis.
J Infect. 2021 Sep 14. pii: S0163-4453(21)00477.
PubMed

QIU S, Wang D, Zhang Y, Hu Y, et al
Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites.
J Infect. 2021 Sep 13. pii: S0163-4453(21)00471.
PubMed

OLEARO F, Norz D, Hoffman A, Grunwald M, et al
Clinical performance and accuracy of a qPCR-based SARS-CoV-2 mass-screening workflow for healthcare-worker surveillance using pooled self-sampled gargling solutions: a cross-sectional study.
J Infect. 2021 Sep 6. pii: S0163-4453(21)00451.
PubMed Abstract available

QIU S, Zhang Y, Wang D, Hu Y, et al
The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.
J Infect. 2021 Sep 2. pii: S0163-4453(21)00449.
PubMed

LIANG J, Wang Z, Liu Y, Zeng L, et al
Epidemiology and co-infection patterns in patients with respiratory tract infections in southern China between 2018 and 2020.
J Infect. 2021;83:e6-e8.
PubMed

CHANDRA S, Rawal R
The surge in Covid related mucormycosis.
J Infect. 2021;83:381-412.
PubMed

ALKALAMOUNI H, Hitti E, Zaraket H
Adopting fresh air ventilation may reduce the risk of airborne transmission of SARS-CoV-2 in COVID-19 unit.
J Infect. 2021 Sep 1. pii: S0163-4453(21)00450.
PubMed

August 2021

BHATTACHARYA A, Collin SM, Stimson J, Thelwall S, et al
Healthcare-associated COVID-19 in England: a national data linkage study.
J Infect. 2021 Aug 30. pii: S0163-4453(21)00443.
PubMed Abstract available

STRALIN K, Bruce D, Wahlstrom E, Walther S, et al
Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden.
J Infect. 2021 Aug 30. pii: S0163-4453(21)00448.
PubMed

SNELL LB, Awan AR, Charalampous T, Alcolea-Medina A, et al
SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition.
J Infect. 2021 Aug 30. pii: S0163-4453(21)00445.
PubMed

QIU S, Hu Y, Cheng L
A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease.
J Infect. 2021 Aug 26. pii: S0163-4453(21)00442.
PubMed

TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected.
J Infect. 2021 Aug 23. pii: S0163-4453(21)00433.
PubMed Abstract available

QIU S, Hu Y
Are COVID-19 susceptibility genes related to lung cancer?
J Infect. 2021 Aug 23. pii: S0163-4453(21)00434.
PubMed

MORALES-ORTEGA A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
J Infect. 2021 Aug 23. pii: S0163-4453(21)00436.
PubMed

GUIGON A, Faure E, Lemaire C, Chopin MC, et al
Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.
J Infect. 2021 Aug 23. pii: S0163-4453(21)00435.
PubMed

KRAL S, Banfi C, Niedrist T, Sareban N, et al
Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.
J Infect. 2021 Aug 22. pii: S0163-4453(21)00419.
PubMed

WEISSMAN YL, Cooper L, Sternbach N, Ashkenazi-Hoffnung L, et al
Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations -a systematic review and meta-analysis.
J Infect. 2021 Aug 20. pii: S0163-4453(21)00417.
PubMed Abstract available

TEYSSOU E, Delagreverie H, Visseaux B, Lambert-Niclot S, et al
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
J Infect. 2021 Aug 19. pii: S0163-4453(21)00416.
PubMed

BRAMLEY A, Crocker-Buque T, Breuer J, Mahungu TW, et al
Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
J Infect. 2021 Aug 19. pii: S0163-4453(21)00418.
PubMed

WANG C, Kang K, Lan X, Fei D, et al
Cytokinelevels in sputum, not serum, may be more helpful 1 for indicating the damage in the lung and the prognosis of severe COVID-19 - A Case Series.
J Infect. 2021 Aug 19. pii: S0163-4453(21)00415.
PubMed Abstract available

YOU YS, Kim JS
Influenza and Anosmia: important prediction factors for severity and death of COVID-19.
J Infect. 2021 Aug 18. pii: S0163-4453(21)00413.
PubMed Abstract available

GAO R, Zheng H, Liu K, Ji Z, et al
Genesis, Evolution and Host Species Distribution of influenza A (H10N3) Virus in China.
J Infect. 2021 Aug 17. pii: S0163-4453(21)00403.
PubMed

KRETSCHMER A, Kossow A, Grune B, Schildgen O, et al
False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden.
J Infect. 2021 Aug 17. pii: S0163-4453(21)00402.
PubMed

DOUXFILS J, Gillot C, Mullier F, Favresse J, et al
Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
J Infect. 2021 Aug 15. pii: S0163-4453(21)00405.
PubMed

ARANDA J, Oriol I, Martin M, Feria L, et al
Long-term impact of COVID-19 associated acute respiratory distress syndrome.
J Infect. 2021 Aug 13. pii: S0163-4453(21)00396.
PubMed Abstract available

WEY EQ, Bristow C, Nandani A, O'Farrell B, et al
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19.
J Infect. 2021 Aug 13. pii: S0163-4453(21)00400.
PubMed

LADHANI SN, Ireland G, Baawuah F, Beckmann J, et al
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England.
J Infect. 2021 Aug 13. pii: S0163-4453(21)00401.
PubMed Abstract available

MOSELEY E, Williams P, Muir P, Marlow R, et al
Influenza A/B and respiratory syncytial virus digital immunoassay evaluation in a paediatric emergency department.
J Infect. 2021 Aug 11. pii: S0163-4453(21)00397.
PubMed

COSTA R, Bueno F, Gimenez E, Bracho A, et al
Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children.
J Infect. 2021 Aug 11. pii: S0163-4453(21)00398.
PubMed

DONG M, Luo M, Li A, Xie H, et al
Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study.
J Infect. 2021 Aug 11. pii: S0163-4453(21)00395.
PubMed

FURUSE Y, Tsnchiya N, Miyahara R, Yasuda D, et al
COVID-19 case-clusters and transmission chains in the communities in Japan.
J Infect. 2021 Aug 11. pii: S0163-4453(21)00399.
PubMed

ALLEN N, Brady M, Martin AIC, Domegan L, et al
Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals.
J Infect. 2021 Aug 9. pii: S0163-4453(21)00394.
PubMed

YAHI N, Chahinian H, Fantini J
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ?
J Infect. 2021 Aug 9. pii: S0163-4453(21)00392.
PubMed Abstract available

KHAN MI, Qureshi H, Khattak AA, Awan UA, et al
Predicting COVID-19 incidence in Pakistan: It's time to act now!
J Infect. 2021 Aug 9. pii: S0163-4453(21)00393.
PubMed

FERNANDEZ-DE-LAS-PENAS C
Post-COVID Functional Limitations on Daily Living Activities are Associated with Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection and Internal Care Unit Admission: A Multicenter Study.
J Infect. 2021 Aug 7. pii: S0163-4453(21)00391.
PubMed

ZHANG J, Huang L, Chen Y, Wang X, et al
Avian influenza H10 subtype viruses continuously pose threat to public health in China.
J Infect. 2021 Aug 6. pii: S0163-4453(21)00386.
PubMed

Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals.
J Infect. 2021 Aug 6. pii: S0163-4453(21)00388.
PubMed

GOBBI F, Buonfrate D, Silva R, Martini D, et al
Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose.
J Infect. 2021 Aug 6. pii: S0163-4453(21)00390.
PubMed

LAMB G, Heskin J, Randell P, Mughal N, et al
Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
J Infect. 2021 Aug 5. pii: S0163-4453(21)00383.
PubMed Abstract available

Predominance of Delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.
J Infect. 2021 Aug 5. pii: S0163-4453(21)00387.
PubMed

TANNER AR, Phan H, Brendish NJ, Borca F, et al
SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death.
J Infect. 2021 Aug 4. pii: S0163-4453(21)00384.
PubMed Abstract available

CHEN J, Li X, Xu L, Xie S, et al
Health threats from increased antigenicity changes in H5N6-dominant subtypes, 2020 China.
J Infect. 2021;83:e9-e11.
PubMed

FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
J Infect. 2021;83:237-279.
PubMed

FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
J Infect. 2021;83:237-279.
PubMed

MILLER E, Waight PA, Andrews NJ, McOwat K, et al
Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
PubMed Abstract available

July 2021

LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
PubMed Abstract available

BENE MC, Bittencourt MC, Chevallier P
Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.
J Infect. 2021 Jul 28. pii: S0163-4453(21)00370.
PubMed

LIM SY, Kim JY, Lee JA, Kwon JS, et al
Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without.
J Infect. 2021 Jul 28. pii: S0163-4453(21)00375.
PubMed

RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
PubMed Abstract available

RANA MS, Usman M, Salman M, Alam MM, et al
Potential impact of COVID-19 Pandemic on escalating antimicrobial resistance in Pakistan.
J Infect. 2021 Jul 27. pii: S0163-4453(21)00368.
PubMed

WHITTAKER R, Kristofferson AB, Seppala E, Salamanca BV, et al
Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.
J Infect. 2021 Jul 27. pii: S0163-4453(21)00366.
PubMed

CIUFFREDA L, Salazar JML, Alcoba-Florez J, Rodriguez-Perez H, et al
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia.
J Infect. 2021 Jul 27. pii: S0163-4453(21)00373.
PubMed

COSENTINO G, Bernard M, Ambroise J, Giannoli JM, et al
SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
J Infect. 2021 Jul 27. pii: S0163-4453(21)00374.
PubMed

EBANKS D, Faustini S, Shields A, Parry H, et al
Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
J Infect. 2021 Jul 26. pii: S0163-4453(21)00363.
PubMed

ROBERT TANNER A
Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance.
J Infect. 2021 Jul 25. pii: S0163-4453(21)00365.
PubMed

GIDARI A, Sabbatini S, Bastianelli S, Pierucci S, et al
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
J Infect. 2021 Jul 25. pii: S0163-4453(21)00362.
PubMed Abstract available

LAI CK, Lui GC, Chen Z, Cheung YY, et al
Comparison of Self-collected Mouth Gargle with Deep-throat Saliva Samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19.
J Infect. 2021 Jul 25. pii: S0163-4453(21)00354.
PubMed

BOU-KARROUM L, Khabsa J, Jabbour M, Hilal N, et al
Public Health Effects of Travel-Related Policies on the COVID-19 Pandemic: A Mixed-Methods Systematic Review.
J Infect. 2021 Jul 24. pii: S0163-4453(21)00360.
PubMed Abstract available

LADHANI SN
Crossing the Rubicon: a Fine Line between Waiting and Vaccinating Adolescents against COVID-19.
J Infect. 2021 Jul 21. pii: S0163-4453(21)00357.
PubMed Abstract available

GUDIOL C, Dura-Miralles X, Aguilar-Company J, Hernandez-Jimenez P, et al
Co-infections and superinfections complicating COVID-19 in cancer patients: a multicenter, international study.
J Infect. 2021 Jul 21. pii: S0163-4453(21)00356.
PubMed Abstract available

MOMBELLI M, Hoschler K, Cavassini M, Pascual M, et al
Seasonal Trivalent Inactivated Influenza Vaccine with Topical Imiquimod in Immunocompromised Patients: a Randomized Controlled Trial.
J Infect. 2021 Jul 20. pii: S0163-4453(21)00353.
PubMed Abstract available

GAO S, Lu Y, Luan J, Zhang L, et al
Low incidence rate of diarrhoea in COVID-19 patients is due to integrin.
J Infect. 2021 Jul 15. pii: S0163-4453(21)00348.
PubMed

MATTIUZZI C, Henry BM, Lippi G
Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?: Symptoms of COVID-19.
J Infect. 2021 Jul 15. pii: S0163-4453(21)00347.
PubMed

VANCHEESWARAN R, Willcox ML, Stuart B, Knight M, et al
Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19.
J Infect. 2021 Jul 14. pii: S0163-4453(21)00332.
PubMed

AVDEEV SN, Gaynitdinova VV, Merzhoeva ZM, Berikkhanov ZG, et al
N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.
J Infect. 2021 Jul 10. pii: S0163-4453(21)00329.
PubMed

NIITSU T, Shiroyama T, Hirata H, Noda Y, et al
Cytomegalovirus infection in critically ill patients with COVID-19.
J Infect. 2021 Jul 9. pii: S0163-4453(21)00330.
PubMed

ANGELETTI S, Giovanetti M, Fogolari M, De Florio L, et al
Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated Health Care worker in Italy.
J Infect. 2021 Jul 5. pii: S0163-4453(21)00325.
PubMed Abstract available

FAVRESSE J, Douxfils J
Importance of Sample Dilution in the Evaluation of the Antibody Response after SARS-CoV-2 Vaccination.
J Infect. 2021 Jul 4. pii: S0163-4453(21)00327.
PubMed

BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
J Infect. 2021;83:119-145.
PubMed

ROCHA AS, Meireles M, Vilaca H, Guimaraes TC, et al
Outcomes of Covid-19 Organizing Pneumonia in Critically Ill Patients: OUTCOMES OF COVID-19 ORGANIZING PNEUMONIA.
J Infect. 2021 Jul 1. pii: S0163-4453(21)00322.
PubMed

June 2021

XIE D, Chu H, Yang D, Ding Q, et al
A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.
J Infect. 2021 Jun 30. pii: S0163-4453(21)00315.
PubMed

SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
J Infect. 2021 Jun 29. pii: S0163-4453(21)00321.
PubMed

HSU L, Wisplinghoff H, Kossow A, Hurrass J, et al
Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.
J Infect. 2021 Jun 29. pii: S0163-4453(21)00320.
PubMed

WANG Y, Niu S, Zhang B, Yang C, et al
The whole genome analysis for the first human infection with H10N3 influenza virus in China.
J Infect. 2021 Jun 27. pii: S0163-4453(21)00318.
PubMed Abstract available

MENDEZ-BRITO A, Bcheraoui CE, Pozo-Martin F
Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.
J Infect. 2021 Jun 20. pii: S0163-4453(21)00316.
PubMed Abstract available

TRE-HARDY M, Cupaiolo R, Wilmet A, Beukinga I, et al
Waning antibodies in SARS-CoV-2 naive vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.
J Infect. 2021 Jun 20. pii: S0163-4453(21)00314.
PubMed

BUSKERMOLEN M, Te Paske K, van Beek J, Kortbeek T, et al
Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: viral reactivation or inflammatory rebound?
J Infect. 2021 Jun 17. pii: S0163-4453(21)00310.
PubMed

DIMEGLIO C, Herin F, Miedouge M, Da-Silva I, et al
One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.
J Infect. 2021 Jun 17. pii: S0163-4453(21)00312.
PubMed

HOMMA Y, Katsuta T, Oka H, Inoue K, et al
The incubation period of the SARS-CoV-2 B.1.1.7 variant is shorter than that of other strains.
J Infect. 2021 Jun 16. pii: S0163-4453(21)00306.
PubMed

ANDERSEN MP, Ostergaard L, Phelps M, Butt JH, et al
Risk of Coronavirus Disease 2019 (Covid-19) Contraction and Severe Infection in Home- or Healthcare Professionals.
J Infect. 2021 Jun 15. pii: S0163-4453(21)00305.
PubMed

CENDEJAS-BUENO E, Romero-Gomez MP, Escosa L, Jimenez-Rodriguez S, et al
Lower nasopharyngeal viral loads in pediatric population. The missing piece to understand SARS-CoV-2 infection in children?
J Infect. 2021 Jun 13. pii: S0163-4453(21)00289.
PubMed Abstract available

LOFFREDO L, Oliva A, Paraninfi A, Ceccarelli G, et al
An observed association between conjunctivitis and severity of COVID-19.
J Infect. 2021 Jun 9. pii: S0163-4453(21)00286.
PubMed

KWOK KO, McNeil EB, Tsoi MTF, Wei VWI, et al
Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
J Infect. 2021 Jun 9. pii: S0163-4453(21)00287.
PubMed Abstract available

NOH JY, Song JY, Hyun HJ, Yoon JG, et al
Risk factors for SARS-CoV-2 transmission in non-household clusters.
J Infect. 2021 Jun 8. pii: S0163-4453(21)00284.
PubMed

RISTIC S, Pavlic SD, Nadalin S, Cizmarevic NS, et al
ACE I/D polymorphism and epidemiological findings for COVID-19: one year after the pandemic outbreak in Europe.
J Infect. 2021 Jun 4. pii: S0163-4453(21)00282.
PubMed

LORENZO VB, Nascimento-Carvalho C
Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection.
J Infect. 2021 Jun 3. pii: S0163-4453(21)00280.
PubMed Abstract available

FANTINI J, Yahi N, Azzaz F, Chahinian H, et al
Structural dynamics of SARS-CoV-2 variants: a health monitoring strategy for anticipating Covid-19 outbreaks.
J Infect. 2021 Jun 2. pii: S0163-4453(21)00281.
PubMed Abstract available

STANG A, Robers J, Schonert B, Jockel KH, et al
The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.
J Infect. 2021 Jun 1. pii: S0163-4453(21)00265.
PubMed

OLEA B, Albert E, Torres I, Gozalvo-Rovira R, et al
Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: relationship with biomarkers of disease severity.
J Infect. 2021 Jun 1. pii: S0163-4453(21)00279.
PubMed

May 2021

KONTOGIANNI K, Cubas-Atienzar AI, Wooding D, Buist K, et al
Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B.1.1.7 lineage.
J Infect. 2021 May 29. pii: S0163-4453(21)00272.
PubMed

TANG JW, Bird PW, Holmes CW, Nicoara DC, et al
The UK Leicester COVID-19 'exceedance' May-July 2020: An analysis of hospitalised cases.
J Infect. 2021 May 29. pii: S0163-4453(21)00270.
PubMed

ZHANG N, Chen X, Jia W, Jin T, et al
Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19.
J Infect. 2021 May 29. pii: S0163-4453(21)00273.
PubMed Abstract available

YAN X, Huang H, Wang C, Jin Z, et al
Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery.
J Infect. 2021 May 29. pii: S0163-4453(21)00276.
PubMed

RAW RK, Kelly C, Rees J, Wroe C, et al
Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
J Infect. 2021 May 29. pii: S0163-4453(21)00277.
PubMed

BUTT AA, Khan T, Yan P, Shaikh OS, et al
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
J Infect. 2021 May 28. pii: S0163-4453(21)00263.
PubMed

PALLOTTO C, Blanc P, Esperti S, Suardi LR, et al
Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
J Infect. 2021 May 28. pii: S0163-4453(21)00267.
PubMed

THANGARAJ JWV, Kumar MS, Kumar CG, Kumar VS, et al
Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.
J Infect. 2021 May 28. pii: S0163-4453(21)00268.
PubMed

BREATHNACH AS, Duncan CJA, Bouzidi KE, Hanrath AT, et al
Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.
J Infect. 2021 May 27. pii: S0163-4453(21)00266.
PubMed

CAPETTI AF, Borgonovo F, Mileto D, Gagliardi G, et al
One-year durability of anti-spike IgG to SARS-CoV-2: preliminary data from the AntiCROWN prospective observational study One year durability of COVID-19 anti-spike IgG.
J Infect. 2021 May 27. pii: S0163-4453(21)00264.
PubMed Abstract available

VENTURAS J, Zamparini J, Shaddock E, Stacey S, et al
Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.
J Infect. 2021 May 26. pii: S0163-4453(21)00262.
PubMed Abstract available

J BP, Jolly B, John N, Bhoyar RC, et al
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
J Infect. 2021 May 24. pii: S0163-4453(21)00260.
PubMed

YAMAMOTO S, Tanaka A, Oshiro Y, Ishii M, et al
Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
J Infect. 2021 May 24. pii: S0163-4453(21)00259.
PubMed

HASAN MJ, Rabbani R, Anam AM, Huq SMR, et al
Secukinumab in severe COVID-19 pneumonia: does it have a clinical impact?: Secukinumab in severe COVID-19.
J Infect. 2021 May 21. pii: S0163-4453(21)00253.
PubMed

SZARPAK L
Mucormycosis - a serious threat in the COVID-19 pandemic?
J Infect. 2021 May 21. pii: S0163-4453(21)00257.
PubMed

FONSECA V, de Jesus R, Adelino T, Reis AB, et al
Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.
J Infect. 2021 May 21. pii: S0163-4453(21)00256.
PubMed

BORDI L, Parisi G, Sberna G, Amendola A, et al
Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: a pilot project.
J Infect. 2021 May 20. pii: S0163-4453(21)00254.
PubMed

CARAMELLO V, Boccuzzi A, Basile V, Ferraro A, et al
Are antigenic tests useful for detecting SARS-CoV-2 infections in patients accessing to emergency departments? Results from a North-West Italy Hospital.
J Infect. 2021 May 20. pii: S0163-4453(21)00255.
PubMed

ZARIF A, Joy M, Sherlock J, Sheppard JP, et al
The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
J Infect. 2021 May 15. pii: S0163-4453(21)00220.
PubMed Abstract available

CHIRICO F, Nucera G, Szarpak L
COVID-19 mortality in Italy: The first wave was more severe and deadly, but only in Lombardy region.
J Infect. 2021 May 13. pii: S0163-4453(21)00248.
PubMed

KOROMPOKI E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, et al
Epidemiology and organ specific sequelae of post-acute COVID19: A Narrative Review.
J Infect. 2021 May 13. pii: S0163-4453(21)00247.
PubMed Abstract available

KOW CS, Merchant HA, Hasan SS
Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.
J Infect. 2021 May 13. pii: S0163-4453(21)00250.
PubMed

HOTHAM M
Potential future implications of the COVID-19 pandemic on Norovirus infections in England.
J Infect. 2021 May 13. pii: S0163-4453(21)00241.
PubMed

MANN JA, Bird PW, Bandi S, Tang JW, et al
Asymptomatic SARS-CoV-2-infected children attending hospital with non-COVID-19 diagnoses, March 2020-February 2021.
J Infect. 2021 May 13. pii: S0163-4453(21)00240.
PubMed

WINCHESTER S, John S, Jabbar K, John I, et al
Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection.
J Infect. 2021 May 13. pii: S0163-4453(21)00251.
PubMed Abstract available

WHITAKER HJ, Elgohari S, Rowe C, Otter AD, et al
Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
J Infect. 2021 May 11. pii: S0163-4453(21)00224.
PubMed Abstract available

FERNANDEZ-VILLA T, Vazquez-Casares A, Rivero-Rodriguez A, Carvajal-Urena A, et al
Rapid antigen test for SARS-CoV-2 and primary health care.
J Infect. 2021 May 7. pii: S0163-4453(21)00226.
PubMed

SANSONE E, Tiraboschi M, Sala E, Albini E, et al
Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
J Infect. 2021 May 6. pii: S0163-4453(21)00225.
PubMed Abstract available

MACLOT F, Bontems S, Meex C, Artesi M, et al
Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant.
J Infect. 2021 May 3. pii: S0163-4453(21)00221.
PubMed

MATAKI N, Ohmura H, Kodama T, Nakamura S, et al
Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19.
J Infect. 2021;82:186-230.
PubMed

RICCO M, Ranzieri S, Marchesi F
Rapid antigen tests for large-scale diagnostic campaigns: A case study from North-Eastern Italy.
J Infect. 2021;82:e39-e40.
PubMed

April 2021

DE PAULA CSY, Palandri GG, Fonseca TS, Vendramini TCA, et al
Gastrointestinal manifestations are associated with severe pediatric COVID-19: a study in tertiary hospital.
J Infect. 2021 Apr 30. pii: S0163-4453(21)00217.
PubMed

GARVEY MI, Wilkinson MAC, Holden E, Shields A, et al
Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
J Infect. 2021 Apr 29. pii: S0163-4453(21)00214.
PubMed

CHUDASAMA DY, Flannagan J, Collin SM, Charlett A, et al
Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012-01) in England.
J Infect. 2021 Apr 29. pii: S0163-4453(21)00216.
PubMed

VUSIRIKALA A, Whitaker H, Jones S, Tessier E, et al
Seroprevalence of SARS-CoV-2 Antibodies in University Students: cross-sectional study, December 2020, England.
J Infect. 2021 Apr 29. pii: S0163-4453(21)00215.
PubMed Abstract available

TEYSSOU E, Soulie C, Visseaux B, Lambert-Niclot S, et al
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
J Infect. 2021 Apr 28. pii: S0163-4453(21)00211.
PubMed

BAEK YJ, Lee YJ, Yoon JS, Sohn Y, et al
Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: a longitudinal study.
J Infect. 2021 Apr 28. pii: S0163-4453(21)00212.
PubMed

BONGIOVANNI M, Arienti R, Bini F, Bodini BD, et al
Differences between the waves in Northern Italy: how the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed.
J Infect. 2021 Apr 28. pii: S0163-4453(21)00210.
PubMed

GARVEY MI, McMurray C, Casey AL, Ratcliffe L, et al
Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust.
J Infect. 2021 Apr 28. pii: S0163-4453(21)00213.
PubMed

GALOW L, Haag L, Kahre E, Blankenburg J, et al
Lower household transmission rates of SARS-CoV-2 from children compared to adults.
J Infect. 2021 Apr 27. pii: S0163-4453(21)00209.
PubMed

MARTIN-SANCHEZ M, Lim WW, Yeung A, Adam DC, et al
COVID-19 transmission in Hong Kong despite universal masking.
J Infect. 2021 Apr 22. pii: S0163-4453(21)00205.
PubMed Abstract available

LI KK, Woo YM, Stirrup O, Hughes J, et al
Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface.
J Infect. 2021 Apr 22. pii: S0163-4453(21)00206.
PubMed Abstract available

CHEN S, Zhang X, Zhou Y, Yang K, et al
COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases.
J Infect. 2021 Apr 22. pii: S0163-4453(21)00204.
PubMed

STOCKDALE AJ, Fyles F, Farrell C, Lewis J, et al
Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR.
J Infect. 2021 Apr 20. pii: S0163-4453(21)00198.
PubMed Abstract available

FAROOQ HZ, Davies E, Brown B, Whitfield T, et al
Real-world SARS CoV-2 Testing in Northern England during the first wave of the COVID-19 Pandemic.
J Infect. 2021 Apr 20. pii: S0163-4453(21)00199.
PubMed Abstract available

FU H, Zhang N, Zheng Y, Jiang N, et al
Risk stratification of cardiac sequelae detected using cardiac magnetic resonance in late convalescence at the six-month follow-up of recovered COVID-19 patients.
J Infect. 2021 Apr 19. pii: S0163-4453(21)00202.
PubMed

BARO B, Rodo P, Ouchi D, Bordoy AE, et al
Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison.
J Infect. 2021 Apr 18. pii: S0163-4453(21)00191.
PubMed Abstract available

KODANA M, Kitagawa Y, Takahashi R, Matsuoka M, et al
Concerns about the clinical usefulness of saliva specimens 1 for the diagnosis of COVID-19.
J Infect. 2021 Apr 16. pii: S0163-4453(21)00194.
PubMed

ALCOBA-FLOREZ J, Lorenzo-Salazar JM, Gil-Campesino H, Inigo-Campos A, et al
Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020.
J Infect. 2021 Apr 12. pii: S0163-4453(21)00168.
PubMed

DONADIO C, Rainone A, Gouronnec A, Belmin J, et al
Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: a case series in a geriatric rehabilitation ward during an outbreak.
J Infect. 2021 Apr 11. pii: S0163-4453(21)00167.
PubMed

BONGIOVANNI M, Marra AM, Bini F, Bodini BD, et al
COVID-19 reinfection in healthcare workers: a case series.
J Infect. 2021 Apr 8. pii: S0163-4453(21)00165.
PubMed

LIU Y, Chen H, Tan W, Kuang Y, et al
Clinical characteristics and outcome of SARS-CoV-2 infection during pregnancy.
J Infect. 2021 Apr 5. pii: S0163-4453(21)00163.
PubMed

TABOADA M, Gonzalez M, Alvarez A, Eiras M, et al
First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?
J Infect. 2021 Apr 4. pii: S0163-4453(21)00160.
PubMed

NAYAGAM JS, Jeyaraj R, Mitchell T, Walder DP, et al
Persistent cholestasis in survivors of SARS-CoV-2.
J Infect. 2021 Apr 4. pii: S0163-4453(21)00162.
PubMed

OGURI S, Fujisawa S, Kamada K, Nakakubo S, et al
Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2.
J Infect. 2021 Apr 3. pii: S0163-4453(21)00159.
PubMed

GARCIA-PACHON E, Grau-Delgado J, Soler-Sempere MJ, Zamora-Molina L, et al
Low prevalence of post-COVID-19 syndrome in patients with asthma.
J Infect. 2021 Apr 2. pii: S0163-4453(21)00156.
PubMed

March 2021

MASIA M, Padilla S, Galiana A, Fernandez-Gonzalez M, et al
Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study.
J Infect. 2021 Mar 29. pii: S0163-4453(21)00152.
PubMed

PILLAI A, Koduri K, Gokhale Y, Venkatesh M, et al
Covid-19 Letter to the Editor.
J Infect. 2021 Mar 28. pii: S0163-4453(21)00154.
PubMed

MULCHANDANI R, Taylor-Philips S, Jones HE, Ades AE, et al
Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers.
J Infect. 2021 Mar 25. pii: S0163-4453(21)00151.
PubMed Abstract available

WILLIAMS CM, Pan D, Decker J, Wisniewska A, et al
Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with covid-19.
J Infect. 2021 Mar 24. pii: S0163-4453(21)00135.
PubMed Abstract available

CHAU DNVV
Rapid whole-genome sequencing to inform COVID-19 outbreak response in Vietnam.
J Infect. 2021 Mar 24. pii: S0163-4453(21)00133.
PubMed

HARRIS RJ, Whitaker HJ, Andrews NJ, Aiano F, et al
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
J Infect. 2021 Mar 22. pii: S0163-4453(21)00132.
PubMed Abstract available

HIROTSU Y, Omata M
Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
J Infect. 2021 Mar 22. pii: S0163-4453(21)00130.
PubMed

MURRAY MJ, McIntosh M, Atkinson C, Mahungu T, et al
Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay.
J Infect. 2021 Mar 19. pii: S0163-4453(21)00127.
PubMed Abstract available

THARMARAJAH E, Buazon A, Patel V, Hannah JR, et al
IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression.
J Infect. 2021 Mar 18. pii: S0163-4453(21)00125.
PubMed Abstract available

WILLIAMS P, McWilliams C, Soomro K, Harding I, et al
The dynamics of procalcitonin in COVID-19 patients admitted to Intensive Care Unit - A multi-centre cohort study in the South West of England, UK.
J Infect. 2021 Mar 18. pii: S0163-4453(21)00128.
PubMed

GARVEY MI, Casey AL, Wilkinson MAC, Ratcliffe L, et al
Details of SARS-CoV-2 reinfections at a major UK tertiary centre.
J Infect. 2021 Mar 17. pii: S0163-4453(21)00122.
PubMed

BIRD PW, Holmes C, Fletcher O, Badhwar V, et al
Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale.
J Infect. 2021 Mar 17. pii: S0163-4453(21)00124.
PubMed Abstract available

SHAN FZ, Zhu LL, Zhang Y, Tang YH, et al
Comparison of the role of neutrophil extracellular traps between patients admitted to the intensive care unit with influenza A and B virus infection.
J Infect. 2021 Mar 15. pii: S0163-4453(21)00121.
PubMed

REBOIRO MLL, Fuentetaja RS, Lopez RG, Castro-Conde BA, et al
Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.
J Infect. 2021 Mar 15. pii: S0163-4453(21)00123.
PubMed

CHAUDHRY Z, Shawe-Taylor M, Rampling T, Cutfield T, et al
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate.
J Infect. 2021 Mar 11. pii: S0163-4453(21)00115.
PubMed Abstract available

YANG H, Hou H, Liang X, Xu J, et al
Lack of significant association between dyslipidemia and COVID-19 mortality.
J Infect. 2021 Mar 5. pii: S0163-4453(21)00114.
PubMed

MARTYN EM, Whitaker H, Gil E, Ighomereho P, et al
Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital.
J Infect. 2021 Mar 4. pii: S0163-4453(21)00098.
PubMed

YOUNG BC, Eyre DW, Jeffery K
Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital.
J Infect. 2021 Mar 1. pii: S0163-4453(21)00096.
PubMed

BADDAL B, Bostanci A, Suer K, Sanlidag T, et al
SARS-CoV-2 was already in circulation in Northern Cyprus in the prepandemic period.
J Infect. 2021 Mar 1. pii: S0163-4453(21)00097.
PubMed

February 2021

PETRONE L, Petruccioli E, Alonzi T, Vanini V, et al
In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy.
J Infect. 2021 Feb 24. pii: S0163-4453(21)00094.
PubMed Abstract available

MENSAH AA, Sinnathamby M, Zaidi A, Coughlan L, et al
SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England.
J Infect. 2021 Feb 24. pii: S0163-4453(21)00093.
PubMed Abstract available

DENNY S, Abdolrasouli A, Elamin T, Gonzalo X, et al
A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave.
J Infect. 2021 Feb 18. pii: S0163-4453(21)00090.
PubMed

SCIMECA M, Mauriello S, Servadei F, Caggiano B, et al
Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death.
J Infect. 2021 Feb 17. pii: S0163-4453(21)00083.
PubMed

ANTONELLI M, Capdevila J, Chaudhari A, Granerod J, et al
Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.
J Infect. 2021 Feb 13. pii: S0163-4453(21)00079.
PubMed Abstract available

BULILETE O, Lorente P, Leiva A, Carandell E, et al
Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care.
J Infect. 2021 Feb 13. pii: S0163-4453(21)00080.
PubMed Abstract available

TORRES I, Poujois S, Albert E, Alvarez G, et al
Point-of-care evaluation of a rapid antigen test (CLINITEST() Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals.
J Infect. 2021 Feb 12. pii: S0163-4453(21)00075.
PubMed

YANG H, Liang X, Hou H, Xu J, et al
The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates.
J Infect. 2021 Feb 11. pii: S0163-4453(21)00078.
PubMed

LORA-TAMAYO J, Maestro G, Lalueza A, Rubio-Rivas M, et al
Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study.
J Infect. 2021 Feb 11. pii: S0163-4453(21)00077.
PubMed

NADAL M, Lassel L, Denis M, Gibelin A, et al
ROLE OF SUPER-SPREADER PHENOMENON IN A COVID-19 CLUSTER AMONG HEALTHCARE WORKERS IN A PRIMARY CARE HOSPITAL.
J Infect. 2021 Feb 10. pii: S0163-4453(21)00074.
PubMed

SCUTT DG, Overall DA
Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
J Infect. 2021 Feb 10. pii: S0163-4453(21)00056.
PubMed

EIGNER U, Verstraeten T, Weil J
Decrease in Norovirus infections in Germany following COVID-19 containment measures.
J Infect. 2021 Feb 10. pii: S0163-4453(21)00076.
PubMed

ADRIELLE DOS SANTOS L, Filho PGG, Silva AMF, Santos JVG, et al
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
J Infect. 2021 Feb 9. pii: S0163-4453(21)00043.
PubMed Abstract available

KEVORKIAN JP, Lopes A, Sene D, Riveline JP, et al
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
J Infect. 2021 Feb 9. pii: S0163-4453(21)00058.
PubMed

LI G, Niu J, Fan X, Chen T, et al
The chilly climate may increase the chance of infecting COVID-19.
J Infect. 2021 Feb 8. pii: S0163-4453(21)00057.
PubMed

DE MONTMOLLIN E, Faille D, Andrieu V, Ajzenberg N, et al
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
J Infect. 2021 Feb 5. pii: S0163-4453(21)00054.
PubMed

BELSKY JA, Tullius BP, Lamb MG, Sayegh R, et al
COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients.
J Infect. 2021 Feb 4. pii: S0163-4453(21)00045.
PubMed Abstract available

MORALES-ORTEGA A, Rivas-Prado L, Frutos-Perez B, Jaenes-Barrios B, et al
Early clinical experience with imatinib in COVID-19: searching for a dual effect.
J Infect. 2021 Feb 4. pii: S0163-4453(21)00051.
PubMed

TOOVEY OTR, Harvey KN, Bird PW, Tang JWW, et al
Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
J Infect. 2021 Feb 3. pii: S0163-4453(21)00047.
PubMed

BORGONOVO F, Passerini M, Piscaglia M, Morena V, et al
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
J Infect. 2021 Feb 3. pii: S0163-4453(21)00048.
PubMed

WILSON-DAVIES ESW, Mahanama AIK, Samaraweera B, Ahmed N, et al
Concerns regarding the sensitivity of the OptiGene direct SARS-CoV-2 LAMP assay and its suitability for use in at-risk groups and hospital staff.
J Infect. 2021 Feb 2. pii: S0163-4453(21)00036.
PubMed

ALMHAWISH N, Karah N, Elferruh Y, Aksh A, et al
Protecting healthcare workers in conflict zones during the COVID-19 pandemic: northwest Syria.
J Infect. 2021 Feb 2. pii: S0163-4453(21)00046.
PubMed

TUBIANA S, Burdet C, Houhou N, Thy M, et al
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in in-hospital workers - the CoV-CONTACT cohort.
J Infect. 2021 Feb 2. pii: S0163-4453(21)00049.
PubMed

FOWLER DV, Douglas DA, Godfrey PK, Williams PA, et al
Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff".
J Infect. 2021;82:282-327.
PubMed

January 2021

DIMEGLIO C, Miedouge M, Loubes JM, Mansuy JM, et al
Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: a modelling study from Toulouse, France.
J Infect. 2021 Jan 31. pii: S0163-4453(21)00044.
PubMed Abstract available

TANAKA A, Yamamoto S, Miyo K, Mizoue T, et al
Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
J Infect. 2021 Jan 29. pii: S0163-4453(21)00032.
PubMed

RANA MS, Usman M, Alam MM, Ikram A, et al
Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.
J Infect. 2021 Jan 29. pii: S0163-4453(21)00041.
PubMed

T U, Am DR, Bm W, Ar H, et al
Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients.
J Infect. 2021 Jan 28. pii: S0163-4453(21)00040.
PubMed

DOWNS LO, Eyre DW, O'Donnell D, Jeffery K, et al
Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers.
J Infect. 2021 Jan 25. pii: S0163-4453(21)00033.
PubMed

ADACHI Y, Shiroyama T, Yamaguchi Y, Murakami T, et al
Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study: Running head: Factors predicting respiratory failure in COVID-19.
J Infect. 2021 Jan 24. pii: S0163-4453(21)00039.
PubMed

ELFIKY AA, Ibrahim IM
Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
J Infect. 2021 Jan 22. pii: S0163-4453(21)00038.
PubMed

XU Y, Liang H, Wen H
Frequent reassortment and potential recombination shape the genetic diversity of influenza D viruses.
J Infect. 2021 Jan 21. pii: S0163-4453(21)00037.
PubMed

DE FRANCESCO MA, Poiesi C, Gargiulo F, Bonfanti C, et al
Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features.
J Infect. 2021 Jan 19. pii: S0163-4453(21)00031.
PubMed

TANG JW, Toovey OTR, Harvey KN, Hui DDS, et al
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
J Infect. 2021 Jan 17. pii: S0163-4453(21)00030.
PubMed

MORENO-PEREZ O, Merino E, Leon-Ramirez JM, Andres M, et al
Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study.
J Infect. 2021 Jan 12. pii: S0163-4453(21)00009.
PubMed Abstract available

BREATHNACH DAS, Riley PA, Cotter MP, Houston AC, et al
Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
J Infect. 2021 Jan 12. pii: S0163-4453(21)00010.
PubMed

GARCIA-ORTEGA A, Oscullo G, Calvillo P, Lopez-Reyes R, et al
INCIDENCE, RISK FACTORS, AND THROMBOTIC LOAD OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR COVID-19 INFECTION.
J Infect. 2021 Jan 10. pii: S0163-4453(21)00007.
PubMed Abstract available

GARRATT AM, Ghanima W, Einvik G, Stavem K, et al
Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions.
J Infect. 2021 Jan 9. pii: S0163-4453(21)00006.
PubMed

ALEMANY A, Baro B, Ouchi D, Rodo P, et al
Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test.
J Infect. 2021 Jan 6. pii: S0163-4453(21)00004.
PubMed

BONGIOVANNI M, Bini F, Giuliani G, Gianturco L, et al
Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
J Infect. 2021 Jan 3. pii: S0163-4453(21)00002.
PubMed

NISHI A, Lee LF, Tsuji H, Takasaki Y, et al
Letter to the Editor: Revisiting the County/city-level Event Risk Assessment during the COVID-19 Pandemic.
J Infect. 2021 Jan 3. pii: S0163-4453(21)00003.
PubMed

December 2020

LIU Y, Li M, Liu D, Luo JF, et al
Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19.
J Infect. 2020 Dec 30. pii: S0163-4453(20)30787.
PubMed

GUO J, Yu H, Yang J, Li Y, et al
Weighted gene co-expression network analysis revealed host transcriptional response to H1N1 influenza A virus infection.
J Infect. 2020 Dec 29. pii: S0163-4453(20)30779.
PubMed

TANG JW, Tambyah PA, Hui DS
Emergence of a new SARS-CoV-2 variant in the UK.
J Infect. 2020 Dec 28. pii: S0163-4453(20)30786.
PubMed

YANG H, Xu J, Liang X, Shi L, et al
Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.
J Infect. 2020 Dec 28. pii: S0163-4453(20)30785.
PubMed

HANRATH AT, Payne BAI, Duncan CJA, van der Loeff IS, et al
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
J Infect. 2020 Dec 26. pii: S0163-4453(20)30781.
PubMed

CHAN HT, Chao CM, Lai CC
Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: a meta-analysis.
J Infect. 2020 Dec 26. pii: S0163-4453(20)30783.
PubMed

TABOADA M, Carinena A, Moreno E, Rodriguez N, et al
Post-COVID-19 functional status six-months after Hospitalization.: Functional status after COVID-19.
J Infect. 2020 Dec 26. pii: S0163-4453(20)30784.
PubMed

KONIG S, Hohenstein S, Ueberham L, Hindricks G, et al
Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just COVID-19?
J Infect. 2020 Dec 23. pii: S0163-4453(20)30777.
PubMed

GANDINI O, Lubrano C
Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.
J Infect. 2020 Dec 20. pii: S0163-4453(20)30775.
PubMed

TURCATO G, Zaboli A, Pfeifer N, Ciccariello L, et al
Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report.
J Infect. 2020 Dec 18. pii: S0163-4453(20)30773.
PubMed

BELLANTI F, Buglio AL, Custodero G, Barbera L, et al
Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient.
J Infect. 2020 Dec 16. pii: S0163-4453(20)30770.
PubMed

AGULLO V, Fernandez-Gonzalez M, Ortiz de la Tabla V, Gonzalo-Jimenez N, et al
Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study.
J Infect. 2020 Dec 9. pii: S0163-4453(20)30768.
PubMed

ZHOU H, Li C, Hu T, Liu T, et al
Total Infectomes of 162 SARS-CoV-2 Cases Using Meta-Transcriptomic Sequencing.
J Infect. 2020 Dec 8. pii: S0163-4453(20)30765.
PubMed

CHEN PJ, Chao CM, Lai CC
Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients.
J Infect. 2020 Dec 7. pii: S0163-4453(20)30766.
PubMed

SALMON D, Slama D, De Broucker T, Karmochkine M, et al
Clinical, virological and imaging profile in patients with Persistent or Resurgent forms of COVID-19: a cross-sectional study.
J Infect. 2020 Dec 4. pii: S0163-4453(20)30762.
PubMed

BARRASA H, Martin A, Maynar J, Rello J, et al
High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: a matter of time?
J Infect. 2020 Dec 4. pii: S0163-4453(20)30761.
PubMed

FRICKE LM, Glockner S, Dreier M, Lange B, et al
Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.
J Infect. 2020 Dec 2. pii: S0163-4453(20)30756.
PubMed Abstract available

PIOVANI D, Christodoulou MN, Hadjidemetriou A, Pantavou K, et al
Effect of early application of social distancing interventions on Covid-19 mortality over the first pandemic wave: an analysis of longitudinal data from 37 countries.
J Infect. 2020 Dec 1. pii: S0163-4453(20)30751.
PubMed Abstract available

PANDEY M, Sisodia S, Bandi S, Roland D, et al
Incidence of spread of clinically relevant SARS-CoV2 infection between children in a tertiary emergency department: An evaluation.
J Infect. 2020;81:979-997.
PubMed

FALCINELLI E, Petito E, Becattini C, De Robertis E, et al
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients.
J Infect. 2020 Dec 1. pii: S0163-4453(20)30760.
PubMed

November 2020

FOWLER VL, Armson B, Gonzales JL, Wise EL, et al
A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
J Infect. 2020 Nov 30. pii: S0163-4453(20)30731.
PubMed Abstract available

FURUSE Y
Risk at mass-gathering events and the usefulness of complementary events during COVID-19 pandemic.
J Infect. 2020 Nov 30. pii: S0163-4453(20)30759.
PubMed

MAANI AA, Al-Jardani A, Karrar H, Petersen E, et al
COVID-19 in a case previously infected with MERS-CoV: no cross immunity.
J Infect. 2020 Nov 30. pii: S0163-4453(20)30754.
PubMed

DUBOUCHER C
SARS-CoV-2 and superimposed infection by trichomonads.
J Infect. 2020 Nov 30. pii: S0163-4453(20)30757.
PubMed

JONES CR, Hamilton FW, Thompson A, Morris TT, et al
SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis.
J Infect. 2020 Nov 30. pii: S0163-4453(20)30755.
PubMed

MOREIRA LVL, de Souza Luna LK, Barbosa GR, Perosa AH, et al
Test on stool samples improves the diagnosis of hospitalized patients: detection of SARS-CoV-2 genomic and subgenomic RNA.
J Infect. 2020 Nov 30. pii: S0163-4453(20)30753.
PubMed

GURGEL RQ, de Sa LC, Souza DRV, Martins AF, et al
SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients.
J Infect. 2020 Nov 30. pii: S0163-4453(20)30752.
PubMed Abstract available

LIU D, Yang J, Feng B, Lu W, et al
Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
J Infect. 2020 Nov 28. pii: S0163-4453(20)30726.
PubMed Abstract available

LAI CC, Chen SY, Yen MY, Lee PI, et al
The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan.
J Infect. 2020 Nov 26. pii: S0163-4453(20)30724.
PubMed

LEVI M, Miglietta A, Romeo G, Bartolacci S, et al
Letter in response to article in Journal of Infection: Impact of Routine Infant BCG Vaccination on COVID-19.
J Infect. 2020 Nov 25. pii: S0163-4453(20)30718.
PubMed

SUI Z, Zhang Y, Tu J, Xie J, et al
Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR.
J Infect. 2020 Nov 25. pii: S0163-4453(20)30716.
PubMed

BERASTEGUI-CABRERA J, Salto-Alejandre S, Valerio M, Perez-Palacios P, et al
SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
J Infect. 2020 Nov 25. pii: S0163-4453(20)30719.
PubMed

ROMERO-GOMEZ MP, Gomez-Sebastian S, Cendejas-Bueno E, Montero-Vega MD, et al
Ct value is not enough to discriminate patients harbouring infective virus.
J Infect. 2020 Nov 25. pii: S0163-4453(20)30720.
PubMed

MAJRA D, Benson J, Pitts J, Stebbing J, et al
SARS-CoV-2 (COVID-19) Superspreader Events.
J Infect. 2020 Nov 24. pii: S0163-4453(20)30717.
PubMed Abstract available

KOWALL B, Nonnemacher M, Brune B, Brinkmann M, et al
A model to identify individuals with a high probability of a SARS-CoV-2 infection.
J Infect. 2020 Nov 24. pii: S0163-4453(20)30721.
PubMed

VOICU S, Chousterman BG, Bonnin P, Deye N, et al
Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.
J Infect. 2020 Nov 20. pii: S0163-4453(20)30714.
PubMed

CHAU NVV, Toan LM, Man DNH, Thao HP, et al
Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.
J Infect. 2020 Nov 19. pii: S0163-4453(20)30713.
PubMed

XIONG X, Jiao X, Li H, Zeng S, et al
Glucocorticoid benefits the ventilatory function of sever/critical COVID-19 patients.
J Infect. 2020 Nov 18. pii: S0163-4453(20)30712.
PubMed

BAUER W, Diehl-Wiesenecker E, Ulke J, Galtung N, et al
Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.
J Infect. 2020 Nov 17. pii: S0163-4453(20)30711.
PubMed

TORRES M, Collins K, Corbit M, Ramirez M, et al
Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting.
J Infect. 2020 Nov 17. pii: S0163-4453(20)30710.
PubMed

POOLE S, Brendish NJ, Clark TW
SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study.
J Infect. 2020 Nov 15. pii: S0163-4453(20)30707.
PubMed Abstract available

COLSON P, Finaud M, Levy N, Lagier JC, et al
Evidence of SARS-CoV-2 re-infection with a different genotype.
J Infect. 2020 Nov 15. pii: S0163-4453(20)30706.
PubMed

AUNG AK, Aitken T, Teh BM, Yu C, et al
Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.
J Infect. 2020 Nov 14. pii: S0163-4453(20)30708.
PubMed Abstract available

HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.
PubMed

RANA MS
Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan.
J Infect. 2020 Nov 13. pii: S0163-4453(20)30705.
PubMed

GARDINER T, Cooke G, Fidler S, Cooper N, et al
The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
J Infect. 2020 Nov 12. pii: S0163-4453(20)30699.
PubMed

CHAN RWY, Chan KC, Chan KYY, Lui GCY, et al
SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population.
J Infect. 2020 Nov 12. pii: S0163-4453(20)30704.
PubMed

YAN Y, Jiang X, Fu J, Huang J, et al
Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
J Infect. 2020 Nov 12. pii: S0163-4453(20)30701.
PubMed

CHARLTON M, Dashey S, Stubbs A, Lai FY, et al
Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO - a single-centre, retrospective observational cohort experience.
J Infect. 2020 Nov 9. pii: S0163-4453(20)30698.
PubMed

JI J, Wu M, Zhong L, Liu Z, et al
Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: a multicenter retrospective cohort study.
J Infect. 2020 Nov 8. pii: S0163-4453(20)30696.
PubMed

ROWLAND TAJ, Whitaker H, Jeffery-Smith A, Lang N, et al
Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic.
J Infect. 2020 Nov 4. pii: S0163-4453(20)30695.
PubMed

ALANIO A, Delliere S, Voicu S, Bretagne S, et al
The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
J Infect. 2020 Nov 4. pii: S0163-4453(20)30694.
PubMed

SAITO S, Asai Y, Matsunaga N, Hayakawa K, et al
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics: Comparison of the two COVID-19 waves in Japan.
J Infect. 2020 Nov 2. pii: S0163-4453(20)30693.
PubMed

SCAGNOLARI C, Bitossi C, Frasca F, Viscido A, et al
Differential toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection.
J Infect. 2020;81:726-735.
PubMed Abstract available

SCHIRINZI A, Pesce F, Laterza R, D'Alise MG, et al
Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department.
J Infect. 2020 Nov 1. pii: S0163-4453(20)30687.
PubMed

October 2020

WANG X, Lin L, Xuan Z, Xu J, et al
Risk communication on behavioral responses during COVID-19 among general population in China: a rapid national study.
J Infect. 2020 Oct 31. pii: S0163-4453(20)30689.
PubMed Abstract available

HAMED E
Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.
J Infect. 2020 Oct 31. pii: S0163-4453(20)30691.
PubMed

DIMEGLIO C, Loubes JM, Mansuy JM, Izopet J, et al
Quantifying the impact of public health protection measures on the spread of SARS-CoV-2.
J Infect. 2020 Oct 28. pii: S0163-4453(20)30686.
PubMed Abstract available

ARAN D, Beachler DC, Lanes S, Overhage JM, et al
Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study.
J Infect. 2020 Oct 27. pii: S0163-4453(20)30683.
PubMed Abstract available

MERLI M, Pasulo L, Perricone G, Travi G, et al
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients.
J Infect. 2020 Oct 27. pii: S0163-4453(20)30685.
PubMed

GUETL K, Moazedi-Fuerst F, Rosskopf K, Brodmann M, et al
SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
J Infect. 2020 Oct 26. pii: S0163-4453(20)30684.
PubMed

CHEN CH, Lai CC, Chao CM, Tang HJ, et al
Zero measles after COVID-19 pandemic in Taiwan Running title: measles and COVID-19.
J Infect. 2020 Oct 26. pii: S0163-4453(20)30679.
PubMed

ALFEHAIDI A, Ahmed SA, Hamed E
A case of SARS-CoV-2 re-infection.
J Infect. 2020 Oct 25. pii: S0163-4453(20)30677.
PubMed

MASIA M, Fernandez-Gonzalez M, Garcia JA, Padilla S, et al
Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19.
J Infect. 2020 Oct 25. pii: S0163-4453(20)30676.
PubMed

MORFELD P, Timmermann B, Gross JV, DeMatteis S, et al
COVID-19: Spatial resolution of excess mortality in Germany and Italy.
J Infect. 2020 Oct 25. pii: S0163-4453(20)30678.
PubMed

WELLBELOVE Z, Walsh C, Perinpanathan T, Lillie P, et al
Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients.
J Infect. 2020 Oct 25. pii: S0163-4453(20)30673.
PubMed

DAHDOUH E, Lazaro-Perona F, Romero-Gomez MP, Mingorance J, et al
Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.
J Infect. 2020 Oct 24. pii: S0163-4453(20)30675.
PubMed

GANDINI O, Criniti A, Gagliardi MC, Ballesio L, et al
Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients.
J Infect. 2020 Oct 22. pii: S0163-4453(20)30654.
PubMed

YANG J, Li Y, Guo J, Luo K, et al
Genetic characterization of an H5N6 avian influenza virus from chickens in Guangdong, China.
J Infect. 2020 Oct 21. pii: S0163-4453(20)30656.
PubMed

MELE M, Henares D, Pino R, Asenjo S, et al
Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.
J Infect. 2020 Oct 21. pii: S0163-4453(20)30655.
PubMed Abstract available

WELLS PM, Doores KJ, Couvreur S, Nunez RM, et al
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
J Infect. 2020 Oct 14. pii: S0163-4453(20)30653.
PubMed Abstract available

WALSH KA, Spillane S, Comber L, Cardwell K, et al
The duration of infectiousness of individuals infected with SARS-CoV-2.
J Infect. 2020 Oct 10. pii: S0163-4453(20)30651.
PubMed Abstract available

RANA MS, Usman M, Alam MM, Ikram A, et al
Impact of COVID-19 pandemic on Measles surveillance in Pakistan.
J Infect. 2020 Oct 8. pii: S0163-4453(20)30650.
PubMed

SONG W, Jia X, Zhang X, Ling Y, et al
Co-infection in COVID-19, a cohort study.
J Infect. 2020 Oct 8. pii: S0163-4453(20)30648.
PubMed

JIA X, Xiao L, Liu Y
False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19.
J Infect. 2020 Oct 8. pii: S0163-4453(20)30649.
PubMed

BI J, Wang S, Wang Y, Yang D, et al
Effect of Administering Subsequent Immune Checkpoint Inhibition in Cancer Patients with Prior COVID-19 Infection.
J Infect. 2020 Oct 8. pii: S0163-4453(20)30647.
PubMed

MAO MH, Guo JJ, Qin LZ, Han ZX, et al
Serial semiquantitative detection of SARS-CoV-2 in saliva samples.
J Infect. 2020 Oct 5. pii: S0163-4453(20)30644.
PubMed

TANG JW, Kalliomaki P, Varila TM, Waris M, et al
Nebulisers as a potential source of airborne virus.
J Infect. 2020;81:647-679.
PubMed

GREEN ST, Cladi L
High time for an efficient and effective internationally-supported Zoonosis Surveillance System?
J Infect. 2020;81:647-679.
PubMed

September 2020

DIMEGLIO C, Herin F, Miedouge M, Cambus JP, et al
Screening for SARS-CoV-2 antibodies among healthcare workers in a University Hospital in Southern France.
J Infect. 2020 Sep 30. pii: S0163-4453(20)30640.
PubMed

KUNDI H, Cetin EHO, Canpolat U, Aras S, et al
The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19.
J Infect. 2020 Sep 28. pii: S0163-4453(20)30636.
PubMed Abstract available

BRENDISH NJ, Poole S, Naidu VV, Mansbridge CT, et al
Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection.
J Infect. 2020 Sep 27. pii: S0163-4453(20)30638.
PubMed Abstract available

SIXT T, Moretto F, Devilliers H, Abdallahoui M, et al
The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials.
J Infect. 2020 Sep 27. pii: S0163-4453(20)30639.
PubMed

MOISEEV S, Brovko M, Tao E, Bulanov N, et al
Sex differences in mortality in the intensive care unit patients with severe COVID-19.
J Infect. 2020 Sep 27. pii: S0163-4453(20)30635.
PubMed

HUANG W, Wu Q, Chen Z, Xiong Z, et al
The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.
J Infect. 2020 Sep 27. pii: S0163-4453(20)30632.
PubMed

MIYAZAWA DD
Letter in response to article in journal of infection: "Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study".
J Infect. 2020 Sep 27. pii: S0163-4453(20)30637.
PubMed

SEATON RA, Gibbons CL, Cooper L, Malcolm W, et al
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
J Infect. 2020 Sep 25. pii: S0163-4453(20)30616.
PubMed Abstract available

SALTO-ALEJANDRE S, Roca-Oporto C, Martin-Gutierrez G, Aviles MD, et al
A quick prediction tool for unfavourable outcome in COVID-19 inpatients:development and internal validation.
J Infect. 2020 Sep 25. pii: S0163-4453(20)30619.
PubMed

WANG S, Fu L, Huang K, Han J, et al
Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019.
J Infect. 2020 Sep 23. pii: S0163-4453(20)30630.
PubMed

STANG A, Standl F, Kowall B, Brune B, et al
Excess mortality due to COVID-19 in Germany.
J Infect. 2020 Sep 19. pii: S0163-4453(20)30596.
PubMed Abstract available

PAGANI G, Conti F, Giacomelli A, Bernacchia D, et al
Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening.
J Infect. 2020 Sep 19. pii: S0163-4453(20)30629.
PubMed

PAN D, Sze S, Rogers B, Bron J, et al
Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
J Infect. 2020 Sep 19. pii: S0163-4453(20)30623.
PubMed

JUAN HC, Chao CM, Lai CC, Tang HJ, et al
Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan.
J Infect. 2020 Sep 19. pii: S0163-4453(20)30624.
PubMed

KOW CS, Hasan SS
The use of antimotility drugs in COVID-19 associated diarrhea.
J Infect. 2020 Sep 19. pii: S0163-4453(20)30592.
PubMed

ORTH-HOLLER D, Eigentler A, Stiasny K, Weseslindtner L, et al
Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
J Infect. 2020 Sep 19. pii: S0163-4453(20)30593.
PubMed

SORIANO MC, Vaquero C, Ortiz-Fernandez A, Caballero A, et al
Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.
J Infect. 2020 Sep 18. pii: S0163-4453(20)30594.
PubMed

LADHANI SN, Chow JY, Atkin S, Brown KE, et al
REGULAR MASS SCREENING FOR SARS-CoV-2 INFECTION IN CARE HOMES ALREADY AFFECTED BY COVID-19 OUTBREAKS: implications of false positive test results.
J Infect. 2020 Sep 16. pii: S0163-4453(20)30621.
PubMed

GANDINI O, Criniti A, Ballesio L, Giglio S, et al
Serum ferritin as an independent risk factor for acute respiratory distress syndrome in COVID-19 patients in Rome Italy.
J Infect. 2020 Sep 15. pii: S0163-4453(20)30617.
PubMed

TANG HJ, Lai CC
The association between corticosteroid uses and mortality among severe COVID-19 patients.
J Infect. 2020 Sep 12. pii: S0163-4453(20)30599.
PubMed

ISHII M, Terai H, Kabata H, Masaki K, et al
Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study.
J Infect. 2020 Sep 10. pii: S0163-4453(20)30590.
PubMed

ELFIKY AA, Ibrahim IM, Ismail AM, Elshemey WM, et al
A possible role for GRP78 in cross vaccination against COVID-19.
J Infect. 2020 Sep 10. pii: S0163-4453(20)30598.
PubMed

RANA DMS, Usman MM, Alam DMM, Khalid DA, et al
First trimester miscarriage in a pregnant woman infected with COVID-19 in Pakistan.
J Infect. 2020 Sep 4. pii: S0163-4453(20)30587.
PubMed

BONGIOVANNI M, Zago T
Acute hepatitis caused by asymptomatic COVID-19 infection.
J Infect. 2020 Sep 3. pii: S0163-4453(20)30586.
PubMed

CHEN HJ, Lin HJ, Wu MC, Tang HJ, et al
The implementation of an active surveillance integrating information technology and drive-through coronavirus testing station for suspected COVID-19 cases.
J Infect. 2020 Sep 2. pii: S0163-4453(20)30585.
PubMed

BARNETT WR, Radhakrishnan M, Macko J, Hinch BT, et al
Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: A retrospective study.
J Infect. 2020 Sep 2. pii: S0163-4453(20)30583.
PubMed

KEVORKIAN JP, Riveline JP, Vandiedonck C, Girard D, et al
Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.
J Infect. 2020 Sep 1. pii: S0163-4453(20)30579.
PubMed

August 2020

AXELL-HOUSE DB, Lavingia R, Rafferty M, Clark E, et al
The Estimation of Diagnostic Accuracy of Tests for COVID-19: A Scoping Review.
J Infect. 2020 Aug 31. pii: S0163-4453(20)30577.
PubMed Abstract available

YANYAN, Jiang X, Wang X, Liu B, et al
CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity.
J Infect. 2020 Aug 29. pii: S0163-4453(20)30576.
PubMed

GRALL I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, et al
Viral spreading in asymptomatic cases with SARS-CoV-2 infections: a Pilot study.
J Infect. 2020 Aug 29. pii: S0163-4453(20)30578.
PubMed

KANAMORI H
Rethinking environmental contamination and fomite transmission of SARS-CoV-2 in the healthcare.
J Infect. 2020 Aug 27. pii: S0163-4453(20)30575.
PubMed

NSN G, C J, R M, P R, et al
High rates of SARS-CoV-2 seropositivity in nursing home residents.
J Infect. 2020 Aug 26. pii: S0163-4453(20)30574.
PubMed

DE LUSIGNAN S, Joy M, Oke J, McGagh D, et al
Disparities in the excess risk of mortality in the first wave of COVID-19: cross sectional study of the English sentinel network.
J Infect. 2020 Aug 25. pii: S0163-4453(20)30564.
PubMed Abstract available

LEI H, Xu X, Xiao S, Wu X, et al
Household transmission of COVID-19-a systematic review and meta-analysis.
J Infect. 2020 Aug 25. pii: S0163-4453(20)30571.
PubMed

LANDI F, Gremese E, Rota E, Carfi' A, et al
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?
J Infect. 2020 Aug 24. pii: S0163-4453(20)30565.
PubMed

GARRIGUES E, Janvier P, Kherabi Y, Bot AL, et al
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
J Infect. 2020 Aug 24. pii: S0163-4453(20)30562.
PubMed

VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.
J Infect. 2020 Aug 24. pii: S0163-4453(20)30568.
PubMed

KORTE W, Buljan M, Rosslein M, Wick P, et al
SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.
J Infect. 2020 Aug 24. pii: S0163-4453(20)30567.
PubMed

ARSHAD Y, Mahmood N, Zaidi SSZ, Sharif S, et al
Detection of SARS-CoV-2 in ophthalmic secretions in Pakistan: A preliminary report.
J Infect. 2020 Aug 24. pii: S0163-4453(20)30569.
PubMed

YAN Y, Liu B, Ding H, Wang X, et al
Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China.
J Infect. 2020 Aug 24. pii: S0163-4453(20)30566.
PubMed

KROEMER M, Spehner L, Vettoretti L, Bouard A, et al
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
J Infect. 2020 Aug 24. pii: S0163-4453(20)30563.
PubMed Abstract available

HE L, Zeng Y, Zeng C, Zhou Y, et al
Positive Rate of Serology and RT-PCR for COVID-19 among Healthcare Workers during Different Periods in Wuhan, China.
J Infect. 2020 Aug 24. pii: S0163-4453(20)30561.
PubMed

GROSSI E, Terruzzi V
Exceptionally high COVID-19 viral load and very long duration of shedding in a young pauci-symptomatic child with autism resident in an Italian nursing home.
J Infect. 2020 Aug 22. pii: S0163-4453(20)30560.
PubMed

LI Z, Xu H, Chen J, Pang Z, et al
Internet-based remote consultation facilitates the medical care of patients with chronic skin diseases during COVID-19 pandemic.
J Infect. 2020 Aug 21. pii: S0163-4453(20)30559.
PubMed

Clinical characteristics and outcome of COVID-19 pneumonia in elderly subjects.
J Infect. 2020 Aug 19. pii: S0163-4453(20)30557.
PubMed

NAKAJIMA K, Abe T, Saji R, Ogawa F, et al
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality.
J Infect. 2020 Aug 19. pii: S0163-4453(20)30555.
PubMed

BONGIOVANNI M, Vignati M, Giuliani G, Manes G, et al
The dilemma of COVID-19 recurrence after clinical recovery.
J Infect. 2020 Aug 15. pii: S0163-4453(20)30553.
PubMed

LIM RH, Chow A, Ho HJ
Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore.
J Infect. 2020 Aug 15. pii: S0163-4453(20)30554.
PubMed

KELLENI MT
SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality.
J Infect. 2020 Aug 15. pii: S0163-4453(20)30552.
PubMed

YUAN Y, Liu D, Zeng S, Wang S, et al
In-hospital Use of ACEI/ARB is associated with lower Risk of Mortality and Critic Illness in COVID-19 Patients with Hypertension: ACEI/ARB protect COVID-19 patients.
J Infect. 2020 Aug 12. pii: S0163-4453(20)30548.
PubMed

SADDIQUE A, Rana MS, Alam MM, Ikram A, et al
"Emergence of co-infection of COVID-19 and dengue: A serious public health threat ".
J Infect. 2020 Aug 12. pii: S0163-4453(20)30545.
PubMed

TOMASSINI S, Kotecha D, Bird PW, Folwell A, et al
Setting the criteria for SARS-CoV-2 reinfection - six possible cases.
J Infect. 2020 Aug 12. pii: S0163-4453(20)30546.
PubMed

Previous cardiovascular surgery significantly increases the risk of developing critical illness in patients with COVID-19.
J Infect. 2020 Aug 12. pii: S0163-4453(20)30544.
PubMed

KINOSHITA M, Tanaka M
Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan.
J Infect. 2020 Aug 11. pii: S0163-4453(20)30547.
PubMed Abstract available

LUIS GARCIA DE GUADIANAROMUALD, Mulero MDR, Olivo MH, Rojas CR, et al
Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: a case series.
J Infect. 2020 Aug 11. pii: S0163-4453(20)30543.
PubMed

DAI CY, Dai TH, Ho HY, Ho CK, et al
The strategies for the Coronavirus Disease 2019 (COVID-19) in Taiwan: A different tale.
J Infect. 2020 Aug 10. pii: S0163-4453(20)30542.
PubMed

KIM YJ, Jeong YJ, Kim SH, Oh AR, et al
Preparing for long-term non-face-to-face outpatient care services during the COVID-19 pandemic.
J Infect. 2020 Aug 7. pii: S0163-4453(20)30540.
PubMed

AL-HATMI AMS, Mohsin J, Al-Huraizi A, Khamis F, et al
COVID-19 associated invasive candidiasis.
J Infect. 2020 Aug 6. pii: S0163-4453(20)30539.
PubMed

HAN J, Gong H, Fu L, Chen P, et al
Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea.
J Infect. 2020 Aug 5. pii: S0163-4453(20)30536.
PubMed

BIRGAND G, Blanckaert K, Deschanvres C, Vaudron A, et al
Testing strategies for the control of COVID-19 in nursing homes: Universal or targeted screening?
J Infect. 2020 Aug 5. pii: S0163-4453(20)30535.
PubMed

BOGLIONE L, Rostagno R, Poletti F, Moglia R, et al
The proper use of corticosteroids for 2019-nCov pneumonia: towards promising results?
J Infect. 2020 Aug 4. pii: S0163-4453(20)30534.
PubMed

WANG Y, Chow A
Dancing with COVID-19 after the Hammer is Lifted: Enhancing Healthcare Worker Surveillance.
J Infect. 2020 Aug 1. pii: S0163-4453(20)30533.
PubMed

GLATMAN-FREEDMAN A, Kaufman Z, Applbaum Y, Dichtiar R, et al
Respiratory Syncytial Virus hospitalization burden: a nation-wide population-based analysis, 2000-2017.
J Infect. 2020;81:297-303.
PubMed Abstract available

ELKINGTON P, Morgan H
Personal respirators for population level control of the COVID19 pandemic.
J Infect. 2020;81:318-356.
PubMed

July 2020

DE ABREU MC
SARS-CoV-2 IgM and IgG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
J Infect. 2020 Jul 30. pii: S0163-4453(20)30513.
PubMed

CHETRIT A, Lechien JR, Ammar A, Chekkoury-Idrissi Y, et al
Magnetic Resonance Imaging of COVID-19 Anosmic Patients Reveals Abnormalities of the Olfactory Bulb: Preliminary Prospective Study.
J Infect. 2020 Jul 30. pii: S0163-4453(20)30509.
PubMed

HAMILTON F, Muir P, Attwood M, Vipond ANB, et al
Kinetics and performance of the Abbott Architect SARS-CoV-2 IgG antibody assay.
J Infect. 2020 Jul 30. pii: S0163-4453(20)30510.
PubMed

PALLETT SJC, Jones R, Pallett MA, Rayment M, et al
Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
J Infect. 2020 Jul 30. pii: S0163-4453(20)30511.
PubMed

BLAIRON L, Mokrane S, Wilmet A, Dessilly G, et al
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.
J Infect. 2020 Jul 30. pii: S0163-4453(20)30514.
PubMed

LADHANI SN, Chow JY, Janarthanan R, Fok J, et al
INCREASED RISK OF SARS-CoV-2 INFECTION IN STAFF WORKING ACROSS DIFFERENT CARE HOMES ENCHANCED CoVID-19 OUTBREAK INVESTIGATIONS IN LONDON CARE HOMES.
J Infect. 2020 Jul 28. pii: S0163-4453(20)30508.
PubMed Abstract available

LU QB, Jiang WL, Zhang X, Li HJ, et al
Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case-control study.
J Infect. 2020 Jul 27. pii: S0163-4453(20)30507.
PubMed

WU J, Xie X, Yang L, Xu X, et al
Mobile health technology combats Covid-19 in China.
J Infect. 2020 Jul 27. pii: S0163-4453(20)30505.
PubMed Abstract available

TU D, Shu J, Wu X, Li H, et al
Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2.
J Infect. 2020 Jul 25. pii: S0163-4453(20)30504.
PubMed

BARNACLE JR, Cairney G, Rainsley J, Mercuri L, et al
Changes in the hospital admission profile of COVID-19 positive patients at a central London trust.
J Infect. 2020 Jul 23. pii: S0163-4453(20)30501.
PubMed

GIL E, Weller S, Rokadiya S, Mirfenderesky M, et al
Letter in Response to 'Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown' Local Experience, National Questions. How Local is Local Enough?
J Infect. 2020 Jul 23. pii: S0163-4453(20)30492.
PubMed

BI J, Lin Y, Zhong R, Jiang G, et al
Prevalence and Clinical Characterization of Cancer Patients with Asymptomatic SARS-CoV-2 Infection History.
J Infect. 2020 Jul 22. pii: S0163-4453(20)30493.
PubMed

VILLAR LM, da Costa VD, Marques BL, da Silva LL, et al
USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS.
J Infect. 2020 Jul 22. pii: S0163-4453(20)30491.
PubMed

SHUAI H, Chu H, Hou Y, Yang D, et al
Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-beta and IFN inducer.
J Infect. 2020 Jul 21. pii: S0163-4453(20)30490.
PubMed Abstract available

ROSSOTTI R, Travi G, Ughi N, Corradin M, et al
SAFETY AND EFFICACY OF ANTI-IL6-RECEPTOR TOCILIZUMAB USE IN SEVERE AND CRITICAL PATIENTS AFFECTED BY CORONAVIRUS DISEASE 2019: A COMPARATIVE ANALYSIS.
J Infect. 2020 Jul 8. pii: S0163-4453(20)30467.
PubMed Abstract available

SALMON D, Bartier S, Hautefort C, Nguyen Y, et al
Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter CORANOSMIA cohort study.
J Infect. 2020 Jul 7. pii: S0163-4453(20)30463.
PubMed Abstract available

LU L, Zhong W, Bian Z, Li Z, et al
A Comparison of Mortality-related Risk Factors of COVID-19, SARS, and MERS: A Systematic Review and Meta-analysis.
J Infect. 2020 Jul 4. pii: S0163-4453(20)30460.
PubMed Abstract available

HUANG W, Lin D, Wang C, Bao C, et al
The determination of release from isolation of COVID-19 patients requires ultra-high sensitivity nucleic acid test technology.
J Infect. 2020 Jul 2. pii: S0163-4453(20)30456.
PubMed

ZHOU J, Tan Y, Li D, He X, et al
Observation and analysis of 26 cases of asymptomatic SARS-COV2 infection.
J Infect. 2020;81:e69-e70.
PubMed

June 2020

BATISSE D, Benech N, Botelho-Nevers E, Bouiller K, et al
Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?
J Infect. 2020 Jun 30. pii: S0163-4453(20)30454.
PubMed Abstract available

GIANNIS D, Ziogas IA
Letter in response to article in journal of infection: "Cardiovascular complications in COVID-19: A systematic review and meta-analysis".
J Infect. 2020 Jun 30. pii: S0163-4453(20)30455.
PubMed

PRAZUCK T, Giache S, Gubavu C, Colin M, et al
Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission.
J Infect. 2020 Jun 28. pii: S0163-4453(20)30448.
PubMed

LIN Z, Long F, Yang Y, Chen X, et al
Serum ferritin as an independent risk factor for severity in COVID-19 patients.
J Infect. 2020 Jun 24. pii: S0163-4453(20)30434.
PubMed

BOUZA E, Perez-Granda MJ, Escribano P, Fernandez-Del Rey R, et al
OUTBREAK OF COVID-19 IN A NURSING HOME IN MADRID.
J Infect. 2020 Jun 24. pii: S0163-4453(20)30437.
PubMed

CANTINI F, Niccoli L, Nannini C, Matarrese D, et al
Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia.
J Infect. 2020 Jun 24. pii: S0163-4453(20)30433.
PubMed

DAUNT A, Perez-Guzman PN, Liew F, Hauck K, et al
Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease.
J Infect. 2020 Jun 21. pii: S0163-4453(20)30430.
PubMed

CLARK TW, Brendish NJ, Poole S, Naidu VV, et al
Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.
J Infect. 2020 Jun 21. pii: S0163-4453(20)30432.
PubMed Abstract available

HATTORI T, Amishima M, Morinaga D, Kamada K, et al
Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples.
J Infect. 2020 Jun 21. pii: S0163-4453(20)30428.
PubMed

GAO Y, Shi C, Chen Y, Shi P, et al
A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China.
J Infect. 2020;80:666-670.
PubMed Abstract available

May 2020

SZE S, Pan D, Williams CML, Wong N, et al
Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19.
J Infect. 2020 May 29. pii: S0163-4453(20)30341.
PubMed

WONG MC, Teoh JY, Huang J, Wong SH, et al
The potential impact of vulnerability and coping capacity on the pandemic control of COVID-19.
J Infect. 2020 May 28. pii: S0163-4453(20)30337.
PubMed

MEYLAN S, Akrour R, Regina J, Bart PA, et al
An Early Warning Score to predict ICU admission in COVID-19 positive patients.
J Infect. 2020 May 28. pii: S0163-4453(20)30324.
PubMed

SAGNELLI C, Gentile V, Tirri R, Macera M, et al
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.
J Infect. 2020 May 28. pii: S0163-4453(20)30322.
PubMed

HU J, Zhang X, Zhang X, Zhao H, et al
COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.
J Infect. 2020 May 28. pii: S0163-4453(20)30334.
PubMed

COLTON H, Ankcorn M, Yavuz M, Tovey L, et al
Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.
J Infect. 2020 May 28. pii: S0163-4453(20)30339.
PubMed

KUNUTSOR SK, Laukkanen JA
Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.
J Infect. 2020 May 28. pii: S0163-4453(20)30325.
PubMed

VARIKASUVU SR, Dutt N
Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.
J Infect. 2020 May 27. pii: S0163-4453(20)30316.
PubMed

BORGHETTI A, Ciccullo A, Paratore M, Rovedi F, et al
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.
J Infect. 2020 May 27. pii: S0163-4453(20)30321.
PubMed

KLEMENT-FRUTOS E, Burrel S, Peytavin G, Marot S, et al
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
J Infect. 2020 May 27. pii: S0163-4453(20)30318.
PubMed Abstract available

Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.
J Infect. 2020 May 27. pii: S0163-4453(20)30317.
PubMed

NOH JY, Yoon JG, Seong H, Choi WS, et al
Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.
J Infect. 2020 May 21. pii: S0163-4453(20)30310.
PubMed

TANG JW, Young S, May S, Bird P, et al
Comparing hospitalised, community and staff COVID-19 infection rates during the early phase of the evolving COVID-19 epidemic.
J Infect. 2020 May 19. pii: S0163-4453(20)30308.
PubMed

CAI C, Ahmed OA, Shen H, Zeng S, et al
Which cancer type has the highest risk of COVID-19 infection?
J Infect. 2020 May 19. pii: S0163-4453(20)30307.
PubMed

SHI L, Wang Y, Wang Y, Duan G, et al
Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.
J Infect. 2020 May 14. pii: S0163-4453(20)30288.
PubMed

JAYARAJ R
Clinical and conceptual comments on "Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis".
J Infect. 2020 May 11. pii: S0163-4453(20)30287.
PubMed

WANG D, Zhou M, Nie X, Qiu W, et al
Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China.
J Infect. 2020;80:e25-e27.
PubMed

January 2020

TOIVONEN L, Karppinen S, Schuez-Havupalo L, Teros-Jaakkola T, et al
Respiratory syncytial virus infections in children 0-24 months of age in the community.
J Infect. 2020;80:69-75.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.